X_CHROM	POS	REF	ALT	CAROL	CAROL_score	CAVA_CSN	CAVA_ENST	CAVA_GENE	CAVA_IMPACT	CAVA_SO	Clinvar_all_submitters	Clinvar_all_traits	Clinvar_clinical_significance	Clinvar_conflicted	Clinvar_pathogenic	Clinvar_review_status	Condel	Condel_score	CaddPhred	CaddRaw	CaddRawRankscore	DannRankscore	DannScore	FathmmConvertedRankscore	FathmmScore	GerpNr	GerpRs	GerpRsRankscore	LrtConvertedRankscore	LrtScore	MetalrRankscore	MetalrScore	MetasvmRankscore	MetasvmScore	MutationassessorRankscore	MutationassessorScore	MutationtasterConvertedRankscore	MutationtasterScore	Phastcons20wayMammalianRankscore	Phastcons7wayVertebrateRankscore	Phylop20wayMammalianRankscore	Phylop7wayVertebrateRankscore	Polyphen2HdivRankscore	Polyphen2HdivScore	Polyphen2HvarRankscore	Polyphen2HvarScore	ProveanConvertedRankscore	ProveanScore	SiftConvertedRankscore	SiftScore	Siphy29wayLogoddsRankscore	Vest3Rankscore	Vest3Score	PERCH	PERCH_noMAF	dbSNP_142_ID	ExAC_r03_AC_Het	ExAC_r03_AC_Hom	ExAC_r03_AC_NFE	ExAC_r03_AF	ExAC_r03_AN_NFE	AACHANGE	HGVS	CAVA_AA	AAPOS	Prediction	HDR_Classification	hdr_del	hdr_not_neutral	orig	set_	variant_type	x_chrom_	a_gvgd_prior	Reported
13	32929387	T	C	Neutral	0	c.7397T>C_p.Val2466Ala	ENST00000380152	BRCA2	MODERATE	missense_variant	ITMI|Emory_Genetics_Laboratory	not_specified|AllHighlyPenetrant|not_specified	Benign			criteria_provided|_single_submitter	neutral	0	0.372	-0.407166	0.0611	0.00476	0.169382719	0.00652	5.95	5.07	5.07	0.67916	0.16773	0.193508	0.00011	0	0.44223	-0.9296			0.08979	1	0.08867	0.06797	0.12769	0.16212					0.02449	0.62	0.00963	1	0.52775	0.14555	0.128	-0.740094	-0.907375	rs169547	718	59912	66634	0.994	66660	A2466V	c.7397C>T	V2466A	2466	NA	Neutral	0	0	1	train	BRCA12_Funct	13		Guidugli et. al, 2013
13	32929405	A	C	Deleterious	0.993	c.7415A>C_p.Lys2472Thr	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Benign|Likely_benign|Uncertain_significance			reviewed_by_expert_panel	deleterious	0.748	15.22	1.839424	0.28191	0.61936	0.993890097	0.00735	5.76	5.19	1.31	0.20644	0.29856	0.010572	0.00497	0.0015	0.48212	-0.8981	0.08161	0	0.08979	1	0.10317	0.00689	0.08592	0.25406	0.26629	0.158	0.22023	0.038	0.31561	-1.25	0.55478	0.011	0.13292	0.59233	0.558	-0.416993	-0.668433	rs80358963	1	NA	1	8.24E-06	65446	K2472T	c.7415A>C	K2472T	2472	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32930577	G	A	Neutral	0.351	c.7448G>A_p.Ser2483Asn	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Benign|Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	neutral	0.111	5.315	0.261716	0.11915	0.03912	0.47993115	0.86427	-2.14	5.48	-2.26	0.06437	0.37213	0.002102	0.6021	0.235	0.55885	-0.7878	0.02696	-0.53	0.21601	0.999109	0.51013	0.48486	0.2183	0.09022	0.02634	0	0.01257	0	0.13822	-0.4	0.00963	1	0.36818	0.3222	0.265	-0.4619	-0.451161	rs80358967	2	NA	2	1.65E-05	66290	S2483N	c.7448G>A	S2483N	2483	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32930591	A	G	Deleterious	1	c.7462A>G_p.Arg2488Gly	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.851	28.9	6.249303	0.86285	0.92778	0.998486257	0.87129	-2.23	5.48	2.95	0.33029	0.62918	5.00E-06	0.9185	0.7606	0.91689	0.5838	0.81627	2.555	0.40908	0.9892	0.7489	0.90892	0.95998	0.92612	0.76378	0.999	0.69161	0.963	0.47816	-2.1	0.78421	0.001	0.56051	0.82051	0.833	0.156923	0.207752	NA	1	NA	NA	8.24E-06	66464	R2488G	c.7462A>G	R2488G	2488	Class C45	Neutral	0	0	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32930593	A	C	Deleterious	1	c.7464A>C_p.Arg2488Ser	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.851	27.4	5.869192	0.80437	0.83271	0.997393648	0.86827	-2.19	5.48	1.7	0.23149	0.62918	5.00E-06	0.90701	0.7282	0.8778	0.3138	0.81627	2.555	0.4019	0.984774	0.69624	0.7879	0.26212	0.92612	0.89865	1	0.85043	0.997	0.42352	-1.8	0.78421	0.001	0.17556	0.76876	0.777	0.203476	0.143301	rs80358969	NA	NA	NA	NA	NA	R2488S	c.7464A>C	R2488S	2488	Class C35	Neutral	0	0	1	test	BRCA12_Funct	13	0.66	This Study
13	32930598	T	C	Neutral	0.96	c.7469T>C_p.Ile2490Thr	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|ITMI|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	hereditary_breast_and_ovarian_cancer|_BROVCA2|Not_specified|not_specified|Familial_cancer_of_breast|AllHighlyPenetrant|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.616	8.41	0.63709	0.15482	0.39144	0.982581361	0.86976	-2.21	5.48	-5.83	0.02126	0.14169	0.326891	0.05224	0.0133	0.36197	-0.9747	0.19213	0.55	0.08979	1	0.49623	0.59096	0.09609	0.76621	0.14363	0.01	0.1274	0.008	0.20582	-0.73	0.29783	0.105	0.01696	0.48136	0.425	-0.318373	-0.341055	rs11571707	1455	141	17	1.40E-02	66496	I2490T	c.7469T>C	I2490T	2490	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32930601	A	C	Deleterious	1	c.7472A>C_p.Gln2491Pro	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.869	27.6	5.930666	0.81406	0.75088	0.996189136	0.85624	-2.03	5.48	5.48	0.80555	0.84324	0	0.92135	0.7687	0.93263	0.7067	0.84154	2.685	0.81033	1	0.55106	0.72479	0.95998	0.92612	0.89865	1	0.97092	1	0.42352	-1.8	0.91219	0	0.78786	0.75383	0.76	0.251968	0.212554	NA	NA	NA	NA	NA	NA	Q2491P	c.7472A>C	Q2491P	2491	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32930601	A	T	Deleterious	1	c.7472A>T_p.Gln2491Leu	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.882	29.5	6.388668	0.88205	0.61093	0.993703044	0.85624	-2.03	5.48	5.48	0.80555	0.84324	0	0.91316	0.7454	0.92353	0.6347	0.76554	2.34	0.58814	0.999999	0.55106	0.72479	0.95998	0.92612	0.89865	1	0.97092	1	0.47816	-2.1	0.91219	0	0.78786	0.69737	0.692	0.192348	0.131971	NA	NA	NA	NA	NA	NA	Q2491L	c.7472A>T	Q2491L	2491	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	This Study
13	32930610	G	A	Deleterious	0.999	c.7481G>A_p.Arg2494Gln	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.779	34	7.273581	0.94737	0.99913	0.999472251	0.90916	-2.77	5.48	4.64	0.5716	0.84324	0	0.90087	0.7113	0.90924	0.5268	0.81747	2.56	0.48823	0.999752	0.62353	0.72479	0.71188	0.60462	0.71542	0.998	0.42795	0.403	0.30542	-1.2	0.91219	0	0.68211	0.60341	0.572	-0.141406	-0.0679297	rs80358973	NA	NA	NA	NA	NA	R2494Q	c.7481G>A	R2494Q	2494	Class C35	Neutral	0	0	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32930613	T	C	Deleterious	1	c.7484T>C_p.Ile2495Thr	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario	not_specified|Familial_cancer_of_breast|Not_specified|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.911	28.5	6.152969	0.84858	0.93768	0.998593966	0.86427	-2.14	5.48	5.48	0.80555	0.84324	0	0.93251	0.8005	0.94175	0.7806	0.82864	2.615	0.50622	0.99989	0.88722	0.90892	0.80647	0.76621	0.89865	1	0.97092	1	0.36563	-1.5	0.91219	0	0.78786	0.67204	0.66	0.161903	0.0869357	rs80358974	NA	NA	NA	NA	NA	I2495T	c.7484T>C	I2495T	2495	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	This Study
13	32930621	A	G	Deleterious	1	c.7492A>G_p.Lys2498Glu	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.829	29.8	6.443017	0.88902	0.97556	0.99904526	0.86427	-2.14	5.48	5.48	0.80555	0.84324	0	0.93485	0.8071	0.94439	0.8021	0.8513	2.74	0.58814	0.999991	0.60234	0.50432	0.95998	0.92612	0.89865	1	0.97092	1	0.30542	-1.2	0.91219	0	0.78786	0.68227	0.673	0.181673	0.12167	NA	NA	NA	NA	NA	NA	K2498E	c.7492A>G	K2498E	2498	Class C55	Deleterious	1	1	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32930633	C	T	Neutral	0.89	c.7504C>T_p.Arg2502Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|CSER_CC_NCGL|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|_University_of_Washington_Medical_Center|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	not_specified|Familial_cancer_of_breast|not_provided|Not_specified|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer	Uncertain_significance			criteria_provided|_multiple_submitters|_no_conflicts	neutral	0.272	15.69	1.916263	0.29111	0.22096	0.930754749	0.85014	-1.95	5.48	0.574	0.16406	0.05607	0.594629	0.73865	0.382	0.57477	-0.7592	0.34687	1.04	0.08979	1	0.01552	0.11554	0.02648	0.11936	0.17377	0.022	0.10362	0.005	0.24674	-0.92	0.27865	0.12	0.028	0.75993	0.767	-0.1002	-0.0430413	rs55716624	36	NA	4	2.97E-04	66524	R2502C	c.7504C>T	R2502C	2502	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32930651	G	A	Deleterious	1	c.7522G>A_p.Gly2508Ser	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|ITMI|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP)	not_specified|Familial_cancer_of_breast|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.906	34	7.228277	0.94608	0.94592	0.998688095	0.86827	-2.19	5.48	5.48	0.80555	0.84324	0	0.93918	0.8192	0.93765	0.7475	0.84617	2.71	0.81033	1	0.45916	0.39045	0.71188	0.60462	0.89865	1	0.97092	1	0.42352	-1.8	0.91219	0	0.96121	0.85239	0.865	0.163078	0.343549	rs80358978	13	NA	NA	1.07E-04	66496	G2508S	c.7522G>A	G2508S	2508	Class C55	Neutral	0	0	1	test	BRCA12_Funct	13	0.66	This Study
13	32930651	G	C	Deleterious	1	c.7522G>C_p.Gly2508Arg	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.945	33	7.023108	0.93825	0.99822	0.999425734	0.89377	-2.52	5.48	5.48	0.80555	0.84324	0	0.94901	0.8471	0.95076	0.8537	0.84617	2.71	0.81033	1	0.45916	0.39045	0.71188	0.60462	0.89865	1	0.97092	1	0.52734	-2.4	0.91219	0	0.96121	0.73759	0.741	0.271579	0.240479	NA	NA	NA	NA	NA	NA	G2508R	c.7522G>C	G2508R	2508	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32930655	G	A	Deleterious	0.999	c.7526G>A_p.Ser2509Asn	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.621	29.6	6.400247	0.88357	0.77509	0.996567716	0.87052	-2.22	5.48	5.48	0.80555	0.62918	5.00E-06	0.92107	0.7679	0.93299	0.7096	0.79086	2.44	0.38184	0.96062	0.65233	0.54028	0.71188	0.60462	0.65671	0.995	0.63721	0.919	0.22729	-0.83	0.72092	0.002	0.78947	0.55032	0.506	-0.00509539	-0.172049	NA	NA	NA	NA	NA	NA	S2509N	c.7526G>A	S2509N	2509	Class C45	Neutral	0	0	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32930658	T	C	Deleterious	1	c.7529T>C_p.Leu2510Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|OMIM|Invitae	Fanconi_anemia|_complementation_group_D1|FANCONI_ANEMIA|_COMPLEMENTATION_GROUP_D1|Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Pathogenic|Uncertain_significance		1	no_assertion_criteria_provided	deleterious	0.945	32	6.817226	0.92596	0.97252	0.99900662	0.91599	-2.89	5.48	5.48	0.80555	0.62918	1.00E-06	0.96031	0.8804	0.96723	0.9713	0.85475	2.76	0.81033	1	0.88722	0.72479	0.80647	0.76621	0.89865	1	0.97092	1	0.47816	-2.1	0.91219	0	0.78786	0.95211	0.955	0.641535	0.706201	rs80358979	NA	NA	NA	NA	NA	L2510P	c.7529T>C	L2510P	2510	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32930673	C	T	Deleterious	1	c.7544C>T_p.Thr2515Ile	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|ITMI|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|not_specified|Familial_cancer_of_breast|not_provided|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Likely_benign			reviewed_by_expert_panel	deleterious	0.859	31	6.547366	0.90129	0.96561	0.998923899	0.8581	-2.05	5.48	4.64	0.5716	0.49728	0.000124	0.83559	0.5509	0.85578	0.18	0.70607	2.14	0.30847	0.609987	0.69624	0.48075	0.48811	0.44667	0.47611	0.9	0.45629	0.493	0.39286	-1.64	0.36462	0.064	0.34704	0.68781	0.68	-0.0803186	-0.0260153	rs28897744	89	1	75	7.49E-04	66416	T2515I	c.7544C>T	T2515I	2515	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32930688	G	T	Deleterious	1	c.7559G>T_p.Arg2520Leu	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.809	34	7.242072	0.94649	0.88724	0.998031563	0.87925	-2.33	5.48	4.63	0.56936	0.84324	0	0.93364	0.8037	0.94375	0.797	0.86275	2.81	0.48657	0.999737	0.55106	0.34634	0.71188	0.60462	0.89865	1	0.80656	0.994	0.47816	-2.1	0.91219	0	0.67117	0.69657	0.691	0.201188	0.11789	NA	NA	NA	NA	NA	NA	R2520L	c.7559G>T	R2520L	2520	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	This Study
13	32930691	T	C	Deleterious	1	c.7562T>C_p.Ile2521Thr	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Familial_cancer_of_breast	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.819	28.2	6.085164	0.83825	0.93313	0.998550937	0.89966	-2.61	5.48	4.23	0.49059	0.44106	0.000476	0.91047	0.7379	0.92887	0.6768	0.75435	2.3	0.35856	0.886901	0.7489	0.33062	0.80647	0.15498	0.62216	0.991	0.55584	0.783	0.3358	-1.35	0.78421	0.001	0.58317	0.76964	0.778	0.249762	0.146394	rs80358984	NA	NA	NA	NA	NA	I2521T	c.7562T>C	I2521T	2521	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32930694	C	T	Deleterious	1	c.7565C>T_p.Ser2522Phe	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.856	34	7.209976	0.94552	0.94502	0.998672785	0.88313	-2.38	5.48	5.48	0.80555	0.62918	6.00E-06	0.94601	0.8385	0.94406	0.7994	0.82864	2.615	0.492	0.999795	0.65233	0.31979	0.48811	0.44667	0.89865	1	0.75945	0.987	0.4197	-1.78	0.78421	0.001	0.96121	0.87638	0.888	0.451964	0.415525	rs80358985	1	NA	1	8.24E-06	66364	S2522F	c.7565C>T	S2522F	2522	Class C25	Neutral	0	0	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32930727	C	G	Deleterious	1	c.7598C>G_p.Ser2533Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.799	25.5	5.195615	0.70142	0.54714	0.99194042	0.86295	-2.12	5.48	4.64	0.5716	0.3517	0.00328	0.89717	0.7012	0.82962	0.0351	0.66975	2.045	0.08979	1	0.27667	0.28153	0.17806	0.44667	0.67003	0.996	0.60075	0.871	0.36563	-1.5	0.78421	0.001	0.439	0.63391	0.611	-0.190954	-0.117173	rs80358987	2	NA	NA	1.65E-05	66222	S2533C	c.7598C>G	S2533C	2533	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32931943	A	C	Deleterious	0.999	c.7682A>C_p.Gln2561Pro	ENST00000380152	BRCA2	MODERATE	missense_variant							neutral	0.454	24.4	4.567418	0.61168	0.35904	0.97854956	0.86089	-2.09	5.15	1.42	0.21324	0.291	0.012603	0.89985	0.7085	0.88683	0.3723	0.72481	2.2	0.37897	0.954993	0.4693	0.36736	0.20865	0.92612	0.57421	0.98	0.65834	0.94	0.40439	-1.7	0.78421	0.001	0.37515	0.74609	0.751	0.142796	0.0802774	NA	NA	NA	NA	NA	NA	Q2561P	c.7682A>C	Q2561P	2561	Class C15	Deleterious	1	1	1	test	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32931945	T	C	Deleterious	1	c.7684T>C_p.Phe2562Leu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Familial_cancer_of_breast	Likely_benign|Uncertain_significance			no_assertion_criteria_provided	deleterious	0.791	29.4	6.353404	0.87738	0.971	0.99898711	0.94549	-3.47	5.15	5.15	0.70107	0.84324	0	0.97309	0.9187	0.98213	1.0544	0.89223	3.02	0.58814	0.999997	0.41664	0.33819	0.42263	0.76621	0.89865	1	0.97092	1	0.42352	-1.8	0.91219	0	0.70746	0.76081	0.768	0.354705	0.334497	rs80358995	NA	NA	NA	NA	NA	F2562L	c.7684T>C	F2562L	2562	Class C15	Deleterious	1	1	1	test	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32931973	A	G	Deleterious	0.999	c.7712A>G_p.Glu2571Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_multiple_submitters|_no_conflicts	deleterious	0.784	32	6.627688	0.90971	0.98506	0.999175796	0.90521	-2.7	5.15	5.15	0.70107	0.84324	1.00E-06	0.94897	0.847	0.95576	0.8928	0.84617	2.71	0.58814	0.999993	0.29694	0.3207	0.64734	0.92612	0.89865	1	0.67576	0.953	0.47816	-2.1	0.78421	0.001	0.70746	0.74353	0.748	0.0779721	0.218744	rs55689095	5	NA	NA	4.12E-05	66722	E2571G	c.7712A>G	E2571G	2571	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32932003	T	G	Deleterious	1	c.7742T>G_p.Leu2581Trp	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.857	28.5	6.163746	0.85021	0.29691	0.965604201	0.91488	-2.87	5.15	5.15	0.70107	0.51284	0.00009	0.95185	0.8554	0.95932	0.918	0.85475	2.76	0.51071	0.999919	0.39256	0.4989	0.42263	0.76621	0.89865	1	0.97092	1	0.4216	-1.79	0.91219	0	0.70746	0.74952	0.755	0.315734	0.2895	rs80359000	NA	NA	NA	NA	NA	L2581W	c.7742T>G	L2581W	2581	Class C55	Neutral	0	0	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32932012	G	A	Deleterious	1	c.7751G>A_p.Gly2584Asp	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.911	32	6.739932	0.91994	0.88455	0.998009205	0.91145	-2.81	5.15	5.15	0.70107	0.84324	0	0.94435	0.8338	0.94938	0.8425	0.68755	2.09	0.81033	1	0.88722	0.90892	0.41381	0.60462	0.89865	1	0.97092	1	0.47816	-2.1	0.91219	0	0.91241	0.8463	0.859	0.167978	0.407937	rs80359001	1	NA	NA	8.24E-06	66726	G2584D	c.7751G>A	G2584D	2584	Class C65	Intermediate	0	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32932014	G	A	Deleterious	1	c.7753G>A_p.Gly2585Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.911	33	6.993888	0.93679	0.99822	0.999422032	0.87052	-2.22	5.15	5.15	0.70107	0.84324	0	0.93804	0.816	0.94647	0.819	0.84617	2.71	0.81033	1	0.88722	0.90892	0.41381	0.60462	0.89865	1	0.97092	1	0.52734	-2.4	0.72092	0.002	0.91241	0.85137	0.864	0.371322	0.371239	rs80359002	NA	NA	NA	NA	NA	G2585R	c.7753G>A	G2585R	2585	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32932020	C	T	Deleterious	1	c.7759C>T_p.Leu2587Phe	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics|GeneDx	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_multiple_submitters|_no_conflicts	deleterious	0.886	29.8	6.439393	0.88853	0.95617	0.998805294	0.91316	-2.84	5.15	5.15	0.70107	0.84324	1.00E-06	0.95535	0.8657	0.96072	0.9278	0.85878	2.785	0.48503	0.999716	0.69624	0.63571	0.32744	0.44667	0.89865	1	0.97092	1	0.30542	-1.2	0.91219	0	0.91241	0.71519	0.714	0.0344207	0.190313	rs56335340	5	NA	5	4.12E-05	66720	L2587F	c.7759C>T	L2587F	2587	Class C15	Neutral	0	0	1	test	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32932027	C	A	Deleterious	1	c.7766C>A_p.Pro2589His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.919	34	7.108627	0.94196	0.70091	0.995382292	0.86561	-2.16	5.15	5.15	0.70107	0.84324	0	0.93574	0.8096	0.94389	0.798	0.82459	2.595	0.81033	1	0.7489	0.44947	0.32744	0.44667	0.89865	1	0.97092	1	0.57554	-2.7	0.91219	0	0.91241	0.73254	0.735	0.239244	0.190822	rs80359005	1	NA	1	8.24E-06	66720	P2589H	c.7766C>A	P2589H	2589	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32932047	G	C	Deleterious	1	c.7786G>C_p.Gly2596Arg	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.945	33	7.022273	0.93821	0.97632	0.999062402	0.92782	-3.12	5.15	5.15	0.70107	0.84324	0	0.96504	0.8946	0.97294	1.0062	0.89223	3.02	0.81033	1	0.7489	0.59096	0.41381	0.60462	0.89865	1	0.97092	1	0.52734	-2.4	0.91219	0	0.91241	0.8732	0.885	0.538357	0.586129	NA	NA	NA	NA	NA	NA	G2596R	c.7786G>C	G2596R	2596	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32932048	G	A	Deleterious	1	c.7787G>A_p.Gly2596Glu	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.945	33	6.923176	0.93291	0.78935	0.996790785	0.92782	-3.12	5.15	5.15	0.70107	0.84324	0	0.96497	0.8944	0.97191	1.0001	0.89223	3.02	0.81033	1	0.7489	0.63571	0.41381	0.60462	0.89865	1	0.97092	1	0.52734	-2.4	0.91219	0	0.91241	0.88065	0.892	0.547875	0.592925	NA	NA	NA	NA	NA	NA	G2596E	c.7787G>A	G2596E	2596	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32936661	G	C	Deleterious	1	c.7807G>C_p.Ala2603Pro	ENST00000380152	BRCA2	MODERATE	splice_region_variant|missense_variant							deleterious	0.859	32	6.825327	0.92652	0.89623	0.998134255	0.90747	-2.74	5.66	5.66	0.87211	0.84324	0	0.9588	0.8759	0.95768	0.9065	0.86584	2.83	0.81033	1	0.55106	0.67089	0.71188	0.60462	0.89865	1	0.97092	1	0.33179	-1.33	0.91219	0	0.97869	0.82833	0.841	0.380763	0.37928	NA	NA	NA	NA	NA	NA	A2603P	c.7807G>C	A2603P	2603	Class C25	Deleterious	1	1	1	test	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32936671	A	G	Deleterious	1	c.7817A>G_p.Asp2606Gly	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.851	33	6.954356	0.9347	0.95778	0.998826208	0.87129	-2.23	5.66	5.66	0.87211	0.84324	0	0.91514	0.751	0.92233	0.6254	0.58897	1.83	0.81033	1	0.88722	0.7879	0.95998	0.92612	0.89865	1	0.97092	1	0.43491	-1.86	0.91219	0	0.81612	0.75819	0.765	0.239912	0.187151	NA	NA	NA	NA	NA	NA	D2606G	c.7817A>G	D2606G	2606	Class C65	Intermediate	0	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32936676	C	G	Deleterious	0.999	c.7822C>G_p.Pro2608Ala	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.766	28	6.048133	0.83248	0.72455	0.995760304	0.86561	-2.16	5.66	5.66	0.87211	0.84324	0	0.93247	0.8004	0.92363	0.6355	0.78603	2.42	0.58814	0.999999	0.69624	0.63571	0.48811	0.44667	0.89865	1	0.87503	0.998	0.48148	-2.12	0.6818	0.003	0.97869	0.71028	0.708	0.194489	0.0955806	NA	NA	NA	NA	NA	NA	P2608A	c.7822C>G	P2608A	2608	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32936680	G	A	Deleterious	1	c.7826G>A_p.Gly2609Asp	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.911	33	6.966067	0.93534	0.89712	0.998145601	0.93238	-3.2	5.66	5.66	0.87211	0.84324	0	0.96821	0.9041	0.96678	0.9684	0.82764	2.61	0.81033	1	0.88722	0.90892	0.71188	0.60462	0.89865	1	0.97092	1	0.43491	-1.86	0.91219	0	0.97869	0.82637	0.839	0.408015	0.410242	rs80359009	NA	NA	NA	NA	NA	G2609D	c.7826G>A	G2609D	2609	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32936680	G	T	Deleterious	1	c.7826G>T_p.Gly2609Val	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.919	33	6.964111	0.93525	0.86582	0.997803091	0.93298	-3.21	5.66	5.66	0.87211	0.84324	0	0.97182	0.9149	0.97371	1.0107	0.88385	2.955	0.81033	1	0.88722	0.90892	0.71188	0.60462	0.89865	1	0.97092	1	0.5257	-2.39	0.91219	0	0.97869	0.80242	0.814	0.397565	0.405813	NA	NA	NA	NA	NA	NA	G2609V	c.7826G>T	G2609V	2609	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32936686	A	G	Deleterious	1	c.7832A>G_p.Asp2611Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.857	33	6.855823	0.92866	0.96715	0.99893827	0.91316	-2.84	5.66	5.66	0.87211	0.84324	0	0.95522	0.8653	0.96121	0.9312	0.86584	2.83	0.81033	1	0.88722	0.90892	0.95998	0.92612	0.89865	1	0.87503	0.998	0.43491	-1.86	0.91219	0	0.81612	0.88389	0.895	0.533154	0.547989	rs80359010	NA	NA	NA	NA	NA	D2611G	c.7832A>G	D2611G	2611	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32936719	A	G	Deleterious	0.999	c.7865A>G_p.Asn2622Ser	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics|Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP)|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_pathogenic|Uncertain_significance		1	criteria_provided|_conflicting_interpretations	deleterious	0.659	27.6	5.925168	0.81324	0.92955	0.998509646	0.90404	-2.68	5.66	5.66	0.87211	0.84324	0	0.95843	0.8748	0.96581	0.9622	0.90698	3.145	0.58814	0.999998	0.5213	0.61045	0.95998	0.92612	0.89865	1	0.91584	0.999	0.32973	-1.32	0.91219	0	0.81612	0.60892	0.579	-0.0920043	0.0295507	rs142899125	7	NA	NA	5.76E-05	66722	N2622S	c.7865A>G	N2622S	2622	Class C45	Deleterious	1	1	1	train	BRCA12_Funct	13	0.66	This Study
13	32936721	C	T	Deleterious	0.999	c.7867C>T_p.His2623Tyr	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.744	31	6.567013	0.90342	0.92778	0.998490629	0.90973	-2.78	5.66	5.66	0.87211	0.84324	0	0.96184	0.885	0.96305	0.9438	0.90019	3.085	0.81033	1	0.56092	0.67089	0.48811	0.44667	0.89865	1	0.97092	1	0.38319	-1.59	0.78421	0.001	0.97869	0.89477	0.905	0.563819	0.616672	NA	NA	NA	NA	NA	NA	H2623Y	c.7867C>T	H2623Y	2623	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	This Study
13	32936722	A	G	Deleterious	0.999	c.7868A>G_p.His2623Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_pathogenic|Uncertain_significance		1	criteria_provided|_conflicting_interpretations	deleterious	0.747	26.3	5.518261	0.74978	0.89264	0.998098349	0.90973	-2.78	5.66	5.66	0.87211	0.84324	0	0.95826	0.8743	0.96405	0.9506	0.90019	3.085	0.81033	1	0.57233	0.72479	0.95998	0.92612	0.89865	1	0.91584	0.999	0.48148	-2.12	0.78421	0.001	0.81612	0.93672	0.942	0.619836	0.686368	rs80359012	NA	NA	NA	NA	NA	H2623R	c.7868A>G	H2623R	2623	Class C25	Deleterious	1	1	1	test	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32936724	T	A	Deleterious	1	c.7870T>A_p.Tyr2624Asn	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.871	33	6.98945	0.93657	0.46769	0.988455323	0.89307	-2.51	5.66	5.66	0.87211	0.84324	0	0.94922	0.8477	0.95704	0.9021	0.89031	3.005	0.81033	1	0.55106	0.7879	0.80647	0.76621	0.89865	1	0.97092	1	0.5257	-2.39	0.91219	0	0.81612	0.84832	0.861	0.393604	0.395524	NA	NA	NA	NA	NA	NA	Y2624N	c.7870T>A	Y2624N	2624	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	This Study
13	32936724	T	C	Deleterious	1	c.7870T>C_p.Tyr2624His	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.863	29.8	6.440575	0.8887	0.88455	0.998004178	0.8916	-2.49	5.66	5.66	0.87211	0.84324	0	0.94922	0.8477	0.95704	0.9021	0.89031	3.005	0.58814	0.999999	0.55106	0.7879	0.80647	0.76621	0.89865	1	0.97092	1	0.33179	-1.33	0.91219	0	0.81612	0.7987	0.81	0.335522	0.320411	NA	NA	NA	NA	NA	NA	Y2624H	c.7870T>C	Y2624H	2624	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	This Study
13	32936724	T	G	Deleterious	1	c.7870T>G_p.Tyr2624Asp	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.871	32	6.715757	0.91787	0.48254	0.989269504	0.89377	-2.52	5.66	5.66	0.87211	0.84324	0	0.94922	0.8477	0.95704	0.9021	0.89031	3.005	0.81033	1	0.55106	0.7879	0.80647	0.76621	0.89865	1	0.97092	1	0.56741	-2.65	0.91219	0	0.81612	0.88389	0.895	0.515827	0.55378	NA	NA	NA	NA	NA	NA	Y2624D	c.7870T>G	Y2624D	2624	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	This Study
13	32936725	A	G	Deleterious	1	c.7871A>G_p.Tyr2624Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Sharing_Clinical_Reports_Project_(SCRP)	Breast-ovarian_cancer|_familial_2|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.882	29.9	6.454269	0.89041	0.86232	0.997758021	0.89444	-2.53	5.66	5.66	0.87211	0.84324	0	0.94897	0.847	0.95519	0.8886	0.89031	3.005	0.81033	1	0.52766	0.7879	0.95998	0.92612	0.89865	1	0.97092	1	0.5257	-2.39	0.91219	0	0.81612	0.91368	0.922	0.562754	0.613786	rs431825358	1	NA	1	8.24E-06	66722	Y2624C	c.7871A>G	Y2624C	2624	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	This Study
13	32936728	G	A	Deleterious	0.999	c.7874G>A_p.Arg2625Lys	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.72	27.9	6.014224	0.82721	0.7828	0.996695039	0.86022	-2.08	5.66	4.81	0.61179	0.84324	0	0.87031	0.6302	0.86185	0.2159	0.5644	1.77	0.4244	0.99483	0.50054	0.90892	0.71188	0.60462	0.54619	0.968	0.52743	0.713	0.22081	-0.8	0.39048	0.052	0.50739	0.67519	0.664	0.0855803	-0.0396288	NA	NA	NA	NA	NA	NA	R2625K	c.7874G>A	R2625K	2625	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32936730	T	C	Deleterious	1	c.7876T>C_p.Trp2626Arg	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.935	29.9	6.468973	0.89221	0.78869	0.996773947	0.92316	-3.03	5.66	5.66	0.87211	0.84324	0	0.96484	0.894	0.97245	1.0033	0.90135	3.095	0.81033	1	0.56092	0.90892	0.80647	0.76621	0.89865	1	0.97092	1	0.70875	-3.73	0.91219	0	0.81612	0.9205	0.928	0.620242	0.681789	NA	NA	NA	NA	NA	NA	W2626R	c.7876T>C	W2626R	2626	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	This Study
13	32936732	G	C	Deleterious	1	c.7878G>C_p.Trp2626Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|Division_of_Human_Genetics_Innsbruck|Medical_University_Innsbruck	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_pathogenic|Pathogenic|Uncertain_significance		1	reviewed_by_expert_panel	deleterious	0.897	33	7.048738	0.93943	0.53778	0.99163176	0.92415	-3.05	5.66	5.66	0.87211	0.84324	0	0.96777	0.9028	0.9695	0.9855	0.90135	3.095	0.81033	1	0.69624	0.90892	0.71188	0.60462	0.89865	1	0.97092	1	0.67779	-3.47	0.91219	0	0.97869	0.92855	0.935	0.639667	0.722579	rs80359013	2	NA	2	1.65E-05	66726	W2626C	c.7878G>C	W2626C	2626	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32936733	A	T	Deleterious	0.999	c.7879A>T_p.Ile2627Phe	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_pathogenic|Pathogenic|Uncertain_significance		1	reviewed_by_expert_panel	deleterious	0.747	27.7	5.954892	0.81789	0.44028	0.986713108	0.90463	-2.69	5.66	4.45	0.53113	0.62918	1.00E-06	0.95409	0.862	0.95635	0.8971	0.90421	3.12	0.58814	0.999996	0.7489	0.7879	0.95998	0.92612	0.89865	1	0.78993	0.992	0.27662	-1.06	0.78421	0.001	0.58001	0.81763	0.83	0.358357	0.320655	rs80359014	NA	NA	NA	NA	NA	I2627F	c.7879A>T	I2627F	2627	Class C15	Deleterious	1	1	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2013
13	32936742	A	C	Deleterious	1	c.7888A>C_p.Lys2630Gln	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.871	28.7	6.208415	0.85685	0.7527	0.996221425	0.90285	-2.66	5.66	5.66	0.87211	0.84324	0	0.95843	0.8748	0.96581	0.9622	0.90698	3.145	0.58814	0.999999	0.88722	0.90892	0.95998	0.92612	0.89865	1	0.97092	1	0.27662	-1.06	0.72092	0.002	0.81612	0.77589	0.785	0.311174	0.288923	NA	NA	NA	NA	NA	NA	K2630Q	c.7888A>C	K2630Q	2630	Class C45	Deleterious	1	1	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32936748	G	T	Deleterious	1	c.7894G>T_p.Ala2632Ser	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.795	32	6.769375	0.92232	0.88994	0.998070445	0.90634	-2.72	5.66	5.66	0.87211	0.84324	0	0.951	0.8529	0.93947	0.7622	0.77793	2.39	0.81033	1	0.88722	0.90892	0.71188	0.60462	0.89865	1	0.97092	1	0.22081	-0.8	0.65363	0.004	0.97869	0.70139	0.697	0.232286	0.179551	NA	NA	NA	NA	NA	NA	A2632S	c.7894G>T	A2632S	2632	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	This Study
13	32936749	C	G	Deleterious	0.999	c.7895C>G_p.Ala2632Gly	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.72	33	6.968737	0.93548	0.92252	0.998425714	0.90634	-2.72	5.66	5.66	0.87211	0.84324	0	0.9572	0.8712	0.95551	0.891	0.8513	2.74	0.81033	1	0.88722	0.90892	0.48811	0.44667	0.89865	1	0.91584	0.999	0.27662	-1.06	0.63171	0.005	0.97869	0.71109	0.709	0.257591	0.212171	NA	NA	NA	NA	NA	NA	A2632G	c.7895C>G	A2632G	2632	Class C55	Neutral	0	0	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32936769	C	G	Deleterious	0.999	c.7915C>G_p.Pro2639Ala	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.755	28.2	6.098345	0.84025	0.73531	0.995934707	0.95046	-3.61	5.66	5.66	0.87211	0.84324	0	0.97333	0.9194	0.97409	1.0129	0.84154	2.685	0.81033	1	0.88722	0.90892	0.48811	0.44667	0.89865	1	0.91584	0.999	0.48148	-2.12	0.72092	0.002	0.97869	0.73759	0.741	0.338566	0.313653	rs80359017	NA	NA	NA	NA	NA	P2639A	c.7915C>G	P2639A	2639	Class C25	Neutral	0	0	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32936770	C	T	Deleterious	1	c.7916C>T_p.Pro2639Leu	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.884	33	7.043989	0.93922	0.96328	0.998886517	0.95114	-3.63	5.66	4.81	0.61179	0.84324	0	0.97296	0.9183	0.9817	1.0524	0.8935	3.03	0.81033	1	0.88722	0.90892	0.48811	0.44667	0.89865	1	0.97092	1	0.56741	-2.65	0.78421	0.001	0.69683	0.78947	0.8	0.358435	0.401628	NA	2	NA	2	1.65E-05	66724	P2639L	c.7916C>T	P2639L	2639	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	This Study
13	32936779	T	C	Deleterious	1	c.7925T>C_p.Phe2642Ser	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.79	33	6.878395	0.93015	0.95205	0.998758326	0.87925	-2.33	5.66	5.66	0.87211	0.55863	0.000021	0.91738	0.7574	0.92158	0.6197	0.64616	1.98	0.52	0.999943	0.88722	0.90892	0.80647	0.76621	0.89865	1	0.91584	0.999	0.48148	-2.12	0.91219	0	0.81612	0.81667	0.829	0.310724	0.27237	NA	NA	NA	NA	NA	NA	F2642S	c.7925T>C	F2642S	2642	Class C45	Deleterious	1	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32936794	T	C	Deleterious	1	c.7940T>C_p.Leu2647Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_pathogenic|Uncertain_significance		1	criteria_provided|_conflicting_interpretations	deleterious	0.889	32	6.654741	0.91236	0.97707	0.999066039	0.91543	-2.88	5.66	5.66	0.87211	0.62918	2.00E-06	0.96494	0.8943	0.97333	1.0085	0.89538	3.045	0.81033	1	0.88722	0.4664	0.80647	0.76621	0.89865	1	0.97092	1	0.43491	-1.86	0.91219	0	0.81612	0.91368	0.922	0.609189	0.673247	rs80359021	NA	NA	NA	NA	NA	L2647P	c.7940T>C	L2647P	2647	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32936808	G	A	Deleterious	1	c.7954G>A_p.Val2652Met	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.85	32	6.796651	0.92443	0.96715	0.998938203	0.91316	-2.84	5.66	5.66	0.87211	0.84324	0	0.9573	0.8715	0.95653	0.8984	0.85475	2.76	0.81033	1	0.58582	0.4989	0.71188	0.60462	0.89865	1	0.97092	1	0.22081	-0.8	0.91219	0	0.97869	0.79963	0.811	0.364759	0.345865	NA	NA	NA	NA	NA	NA	V2652M	c.7954G>A	V2652M	2652	Class C15	Neutral	0	0	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32936812	T	C	Deleterious	1	c.7958T>C_p.Leu2653Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Pathogenic|Uncertain_significance		1	criteria_provided|_conflicting_interpretations	deleterious	0.871	31	6.593798	0.90626	0.96406	0.998905535	0.90859	-2.76	5.66	5.66	0.87211	0.84324	0	0.95532	0.8656	0.96211	0.9374	0.87481	2.89	0.81033	1	0.5213	0.63571	0.80647	0.76621	0.89865	1	0.97092	1	0.43491	-1.86	0.91219	0	0.81612	0.98362	0.981	0.633094	0.703589	rs80359022	NA	NA	NA	NA	NA	L2653P	c.7958T>C	L2653P	2653	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32936815	T	C	Deleterious	1	c.7961T>C_p.Leu2654Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.889	29.9	6.455588	0.89057	0.96484	0.998911115	0.86901	-2.2	5.66	5.66	0.87211	0.55863	0.00003	0.93307	0.8021	0.94064	0.7717	0.82459	2.595	0.81033	1	0.58582	0.72479	0.80647	0.76621	0.89865	1	0.87503	0.998	0.43491	-1.86	0.91219	0	0.81612	0.84427	0.857	0.348191	0.328289	rs80359023	NA	NA	NA	NA	NA	L2654P	c.7961T>C	L2654P	2654	Class C65	Intermediate	0	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32936818	A	G	Deleterious	1	c.7964A>G_p.Gln2655Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.863	29.1	6.289231	0.86853	0.96715	0.998937394	0.89307	-2.51	5.66	5.66	0.87211	0.84324	0	0.94273	0.8292	0.94631	0.8177	0.84154	2.685	0.58814	0.999999	0.88722	0.90892	0.95998	0.92612	0.89865	1	0.97092	1	0.27662	-1.06	0.91219	0	0.81612	0.80807	0.82	0.330996	0.310111	rs80359024	NA	NA	NA	NA	NA	Q2655R	c.7964A>G	Q2655R	2655	Class C35	Deleterious	1	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32936829	A	G	Deleterious	1	c.7975A>G_p.Arg2659Gly	ENST00000380152	BRCA2	MODERATE	splice_region_variant|missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Familial_cancer_of_breast	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.911	28.9	6.257627	0.86403	0.97023	0.998980388	0.9103	-2.79	5.66	4.45	0.53113	0.62918	1.00E-06	0.95454	0.8633	0.95667	0.8994	0.90082	3.09	0.58814	0.999998	0.88722	0.52366	0.95998	0.92612	0.89865	1	0.97092	1	0.43491	-1.86	0.91219	0	0.57661	0.90248	0.912	0.560257	0.610038	rs80359026	NA	NA	NA	NA	NA	R2659G	c.7975A>G	R2659G	2659	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937317	T	G	Deleterious	1	c.7978T>G_p.Tyr2660Asp	ENST00000380152	BRCA2	MODERATE	splice_region_variant|missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Familial_cancer_of_breast	Likely_pathogenic|Uncertain_significance		1	no_assertion_criteria_provided	deleterious	0.935	29.7	6.423564	0.88657	0.47628	0.988939406	0.91316	-2.84	4.93	4.93	0.64188	0.5373	0.000045	0.95653	0.8692	0.96604	0.9637	0.90019	3.085	0.58814	0.999999	0.51013	0.63571	0.63346	0.76621	0.89865	1	0.97092	1	0.61237	-2.93	0.91219	0	0.69963	0.90359	0.913	0.587707	0.645138	rs80359029	NA	NA	NA	NA	NA	Y2660D	c.7978T>G	Y2660D	2660	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937324	C	T	Neutral	0.46	c.7985C>T_p.Thr2662Met	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	neutral	0.007	22	2.934124	0.41312	0.08736	0.695682063	0.84784	-1.92	4.93	4.93	0.64188	0.09294	0.804042	0.64858	0.2765	0.5393	-0.8205	0.01359	-0.895	0.18614	0.999979	0.4392	0.48486	0.20865	0.25177	0.06737	0.001	0.01257	0	0.0167	0.88	0.16712	0.257	0.45948	0.45706	0.398	-0.366309	-0.32862	NA	NA	NA	NA	NA	NA	T2662M	c.7985C>T	T2662M	2662	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32937326	G	A	Deleterious	1	c.7987G>A_p.Glu2663Lys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.861	34	7.139375	0.94313	0.96946	0.998967382	0.90031	-2.62	4.93	4.93	0.64188	0.84324	0	0.95977	0.8788	0.96847	0.9791	0.90534	3.13	0.81033	1	0.51013	0.59096	0.61215	0.60462	0.89865	1	0.97092	1	0.30333	-1.19	0.91219	0	0.90798	0.82441	0.837	0.380808	0.387887	rs80359030	1	NA	1	8.24E-06	64790	E2663K	c.7987G>A	E2663K	2663	Class C55	Deleterious	1	1	1	train	BRCA12_Funct	13	0.66	This Study
13	32937333	A	G	Deleterious	1	c.7994A>G_p.Asp2665Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Benign|Likely_benign			criteria_provided|_multiple_submitters|_no_conflicts	deleterious	0.85	32	6.677214	0.91443	0.93586	0.998575794	0.91316	-2.84	4.93	4.93	0.64188	0.84324	0	0.94734	0.8423	0.95192	0.863	0.80569	2.505	0.58814	0.999999	0.48478	0.52366	0.89267	0.92612	0.89865	1	0.97092	1	0.47479	-2.08	0.91219	0	0.69963	0.83925	0.852	0.196471	0.378547	rs28897745	16	NA	15	1.32E-04	65306	D2665G	c.7994A>G	D2665G	2665	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937348	C	T	Deleterious	1	c.8009C>T_p.Ser2670Leu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_pathogenic|Uncertain_significance		1	criteria_provided|_conflicting_interpretations	deleterious	0.911	35	7.637537	0.95388	0.98223	0.999134571	0.83827	-1.79	4.93	4.93	0.64188	0.62918	0.000011	0.92043	0.7661	0.93509	0.7267	0.8871	2.98	0.58814	0.999999	0.54239	0.63571	0.4006	0.44667	0.89865	1	0.97092	1	0.4197	-1.78	0.78421	0.001	0.90798	0.84327	0.856	0.342202	0.328026	rs80359035	NA	NA	NA	NA	NA	S2670L	c.8009C>T	S2670L	2670	Class C15	Deleterious	1	1	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32937353	A	G	Deleterious	0.999	c.8014A>G_p.Ile2672Val	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	neutral	0.446	24.6	4.693794	0.62913	0.63492	0.994211101	0.81413	-1.51	4.93	2.38	0.28178	0.62918	0.000012	0.82154	0.5216	0.81188	-0.0514	0.58757	1.825	0.30479	0.654795	0.49623	0.59096	0.07723	0.20288	0.57749	0.981	0.60075	0.871	0.11931	-0.3	0.65363	0.004	0.29236	0.61442	0.586	-0.308661	-0.232846	rs80359037	1	NA	NA	8.24E-06	66220	I2672V	c.8014A>G	I2672V	2672	Class C15	Neutral	0	0	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32937354	T	C	Deleterious	0.999	c.8015T>C_p.Ile2672Thr	ENST00000380152	BRCA2	MODERATE	missense_variant							neutral	0.466	27.3	5.867044	0.80402	0.72876	0.995829416	0.82454	-1.63	4.93	4.93	0.64188	0.62918	0.000012	0.90514	0.723	0.92273	0.6284	0.83163	2.63	0.40796	0.988617	0.51013	0.57508	0.63346	0.76621	0.76378	0.999	0.77437	0.99	0.3237	-1.29	0.78421	0.001	0.69963	0.69657	0.691	-0.0392783	0.0939457	rs201483108	1	NA	NA	8.24E-06	66234	I2672T	c.8015T>C	I2672T	2672	Class C65	Intermediate	0	1	1	train	BRCA12_Funct	13	0.81	This Study
13	32937366	T	C	Neutral	0.29	c.8027T>C_p.Met2676Thr	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Benign|Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	neutral	0.005	11.55	1.162345	0.20612	0.08901	0.701035697	0.79677	-1.31	5.08	2.59	0.29847	0.41427	0.00085	0.61085	0.2423	0.48988	-0.8897	0.26164	0.785	0.27191	0.924378	0.88722	0.7879	0.63346	0.76621	0.29429	0.248	0.25748	0.064	0.32773	-1.31	0.08772	0.458	0.33615	0.59947	0.567	-0.12245	-0.326886	rs80359038	1	NA	1	8.24E-06	66452	M2676T	c.8027T>C	M2676T	2676	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32937371	A	G	Deleterious	1	c.8032A>G_p.Arg2678Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Familial_cancer_of_breast	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.819	29.6	6.395442	0.88295	0.94682	0.998697612	0.79287	-1.27	5.08	5.08	0.68184	0.84324	1.00E-06	0.8317	0.5427	0.83381	0.0568	0.52483	1.645	0.5297	0.99996	0.88722	0.90892	0.89267	0.92612	0.89865	1	0.722	0.977	0.4714	-2.06	0.78421	0.001	0.72126	0.70542	0.702	0.125837	0.000613165	rs80359039	NA	NA	NA	NA	NA	R2678G	c.8032A>G	R2678G	2678	Class C45	Neutral	0	0	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32937375	A	G	Deleterious	1	c.8036A>G_p.Asp2679Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.85	31	6.546788	0.9012	0.9625	0.998877222	0.88003	-2.34	5.08	5.08	0.68184	0.84324	0	0.94432	0.8337	0.95699	0.9017	0.92112	3.28	0.58814	0.999999	0.7489	0.90892	0.89267	0.92612	0.76378	0.999	0.97092	1	0.47479	-2.08	0.91219	0	0.72126	0.93555	0.941	0.581297	0.655147	rs80359041	1	NA	NA	8.24E-06	66580	D2679G	c.8036A>G	D2679G	2679	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937378	A	G	Deleterious	1	c.8039A>G_p.Asp2680Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.871	31	6.56585	0.90328	0.96328	0.99889106	0.80912	-1.45	5.08	5.08	0.68184	0.84324	0	0.89878	0.7056	0.91573	0.5749	0.86275	2.81	0.58814	0.999999	0.7489	0.72479	0.89267	0.92612	0.89865	1	0.87503	0.998	0.46303	-2.01	0.78421	0.001	0.72126	0.83426	0.847	0.295957	0.268709	rs80359042	NA	NA	NA	NA	NA	D2680G	c.8039A>G	D2680G	2680	Class C15	Neutral	0	0	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32937396	T	C	Deleterious	1	c.8057T>C_p.Leu2686Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.945	27.2	5.835636	0.7991	0.96172	0.998873162	0.84134	-1.83	5.08	3.9	0.4397	0.62918	0.000011	0.91191	0.7419	0.91302	0.5548	0.85792	2.78	0.81033	1	0.88722	0.7879	0.63346	0.76621	0.89865	1	0.7489	0.985	0.47479	-2.08	0.91219	0	0.4581	0.79038	0.801	0.249225	0.214483	rs28897746	NA	NA	NA	NA	NA	L2686P	c.8057T>C	L2686P	2686	Class C45	Deleterious	1	1	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32937398	G	T	Deleterious	1	c.8059G>T_p.Val2687Phe	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.881	27.6	5.936061	0.81496	0.72089	0.995701321	0.84784	-1.92	5.08	3.34	0.37093	0.51284	0.000083	0.92383	0.7758	0.9252	0.6479	0.90916	3.165	0.51338	0.999922	0.88722	0.7879	0.61215	0.60462	0.89865	1	0.7645	0.988	0.36361	-1.49	0.91219	0	0.49875	0.89917	0.909	0.473413	0.478643	rs80359044	NA	NA	NA	NA	NA	V2687F	c.8059G>T	V2687F	2687	Class C0	Deleterious	1	1	1	test	BRCA12_Funct	13	0.03	This Study
13	32937402	T	C	Deleterious	1	c.8063T>C_p.Leu2688Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Familial_cancer_of_breast	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.945	28	6.038495	0.83099	0.97405	0.999033251	0.89444	-2.53	5.08	5.08	0.68184	0.84324	0	0.9528	0.8582	0.96423	0.9518	0.92549	3.325	0.81033	1	0.69624	0.67089	0.63346	0.76621	0.89865	1	0.97092	1	0.47479	-2.08	0.91219	0	0.72126	0.9691	0.969	0.614062	0.681614	rs80359045	NA	NA	NA	NA	NA	L2688P	c.8063T>C	L2688P	2688	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937411	C	T	Deleterious	1	c.8072C>T_p.Ser2691Phe	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.935	28.4	6.128453	0.84488	0.90157	0.998191238	0.8317	-1.71	5.08	4.22	0.48893	0.50438	0.000102	0.91546	0.7519	0.93757	0.7469	0.88842	2.99	0.38514	0.966271	0.47504	0.7879	0.13888	0.44667	0.89865	1	0.97092	1	0.4197	-1.78	0.91219	0	0.77081	0.76169	0.769	0.22766	0.168223	rs80359047	NA	NA	NA	NA	NA	S2691F	c.8072C>T	S2691F	2691	Class C0	Deleterious	1	1	1	train	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32937429	G	A	Neutral	0.39	c.8090G>A_p.Ser2697Asn	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Benign|Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	neutral	0.004	0.165	-0.550738	0.0526	0.03771	0.470856951	0.80137	-1.36	5.38	0.533	0.16171	0.20036	0.097003	0.61625	0.2469	0.41167	-0.949	0.33833	1.02	0.08979	1	0.15991	0.33206	0.61215	0.60462	0.06737	0.001	0.03956	0.001	0.09644	-0.17	0.09385	0.435	0.04718	0.46071	0.402	-0.418238	-0.395671	rs80359051	6	NA	3	4.94E-05	66714	S2697N	c.8090G>A	S2697N	2697	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32937450	C	T	Deleterious	1	c.8111C>T_p.Ser2704Phe	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|_University_of_Washington_Medical_Center|CSER_CC_NCGL|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast_cancer|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.848	19.42	2.492997	0.36084	0.67191	0.994912407	0.80828	-1.44	5.38	3.6	0.40107	0.15564	0.247779	0.85725	0.599	0.76422	-0.2483	0.7759	2.38	0.08979	1	0.34881	0.35061	0.4006	0.44667	0.54244	0.966	0.58168	0.837	0.39664	-1.66	0.78421	0.001	0.42015	0.79963	0.811	0.0306943	0.095132	rs80359054	4	NA	4	3.30E-05	66718	S2704F	c.8111C>T	S2704F	2704	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32937454	C	G	Deleterious	0.999	c.8115C>G_p.Ser2705Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.557	23.5	3.941045	0.53056	0.49307	0.989798323	0.80828	-1.44	5.38	3.66	0.40843	0.34726	0.003598	0.76294	0.416	0.66869	-0.5485	0.61771	1.905	0.08979	1	0.31529	0.32039	0.15121	0.14223	0.34332	0.454	0.37997	0.266	0.29514	-1.15	0.51801	0.016	0.35298	0.60814	0.578	-0.0979198	-0.286681	rs587781889	NA	NA	NA	NA	NA	S2705R	c.8115C>G	S2705R	2705	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32937473	G	A	Neutral	0.956	c.8134G>A_p.Asp2712Asn	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	neutral	0.359	16.21	1.999654	0.3012	0.74304	0.996058814	0.80572	-1.41	5.49	4.58	0.55833	0.15711	0.24051	0.8498	0.582	0.76723	-0.2369	0.7631	2.33	0.18203	0.999987	0.26291	0.20788	0.61215	0.60462	0.54619	0.968	0.55139	0.773	0.29312	-1.14	0.49066	0.021	0.71404	0.49278	0.438	-0.0819629	-0.279073	rs80359056	NA	NA	NA	NA	NA	D2712N	c.8134G>A	D2712N	2712	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32937488	G	T	Neutral	0.978	c.8149G>T_p.Ala2717Ser	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|ITMI|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Not_specified|not_specified|Familial_cancer_of_breast|not_provided|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Likely_benign			reviewed_by_expert_panel	deleterious	0.674	13.19	1.477447	0.23995	0.74785	0.996135938	0.80047	-1.35	5.49	4.5	0.54134	0.44509	0.000424	0.82438	0.5275	0.74669	-0.3119	0.64222	1.965	0.26111	0.960687	0.26627	0.15022	0.07196	0.60462	0.52538	0.955	0.54724	0.763	0.14603	-0.44	0.28109	0.118	0.51889	0.66735	0.654	-0.168172	-0.129628	rs28897747	141	NA	118	1.16E-03	66734	A2717S	c.8149G>T	A2717S	2717	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32937501	T	A	Deleterious	1	c.8162T>A_p.Leu2721His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.935	27.2	5.834867	0.79896	0.36354	0.979190239	0.85479	-2.01	5.49	5.49	0.80903	0.49728	0.000129	0.93106	0.7964	0.9444	0.8022	0.89905	3.075	0.4583	0.998987	0.5213	0.32417	0.63346	0.76621	0.89865	1	0.97092	1	0.45368	-1.96	0.91219	0	0.75912	0.86061	0.873	0.408518	0.397761	rs80359061	NA	NA	NA	NA	NA	L2721H	c.8162T>A	L2721H	2721	Class C25	Deleterious	1	1	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32937504	C	G	Deleterious	1	c.8165C>G_p.Thr2722Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|OMIM|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|RECLASSIFIED_-_VARIANT_OF_UNKNOWN_SIGNIFICANCE|Neoplastic_Syndromes|_Hereditary	Pathogenic|Uncertain_significance		1	reviewed_by_expert_panel	deleterious	0.935	27.1	5.792566	0.79227	0.55106	0.992069832	0.83749	-1.78	5.49	5.49	0.80903	0.84324	0	0.92785	0.7873	0.9394	0.7616	0.91969	3.265	0.81033	1	0.69624	0.44245	0.4006	0.44667	0.89865	1	0.97092	1	0.4197	-1.78	0.91219	0	0.9435	0.97154	0.971	0.564388	0.618489	rs80359062	NA	NA	NA	NA	NA	T2722R	c.8165C>G	T2722R	2722	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937506	G	C	Deleterious	1	c.8167G>C_p.Asp2723His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Pathogenic|Uncertain_significance		1	reviewed_by_expert_panel	deleterious	0.935	27.1	5.80205	0.79377	0.56404	0.992476682	0.96247	-3.97	5.49	5.49	0.80903	0.84324	0	0.98529	0.9546	0.99482	1.0958	0.93054	3.38	0.81033	1	0.88722	0.59096	0.61215	0.60462	0.89865	1	0.97092	1	0.47479	-2.08	0.91219	0	0.9435	0.96788	0.968	0.708024	0.806778	rs41293511	NA	NA	NA	NA	NA	D2723H	c.8167G>C	D2723H	2723	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937507	A	C	Deleterious	1	c.8168A>C_p.Asp2723Ala	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.911	25.8	5.327765	0.72107	0.73827	0.995987201	0.96212	-3.96	5.49	5.49	0.80903	0.84324	0	0.9839	0.9505	0.99706	1.1011	0.93054	3.38	0.58814	0.999999	0.88722	0.67089	0.89267	0.92612	0.89865	1	0.97092	1	0.52409	-2.38	0.91219	0	0.75912	0.9764	0.975	0.706603	0.8051	rs41293513	1	NA	1	8.24E-06	66736	D2723A	c.8168A>C	D2723A	2723	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937507	A	G	Deleterious	1	c.8168A>G_p.Asp2723Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Pathogenic|Uncertain_significance		1	reviewed_by_expert_panel	deleterious	0.886	26.4	5.568874	0.75752	0.95205	0.998750397	0.96179	-3.95	5.49	5.49	0.80903	0.84324	0	0.9839	0.9505	0.99706	1.1011	0.93054	3.38	0.81033	1	0.88722	0.67089	0.89267	0.92612	0.89865	1	0.97092	1	0.47479	-2.08	0.91219	0	0.75912	0.89807	0.908	0.643873	0.722186	rs41293513	NA	NA	NA	NA	NA	D2723G	c.8168A>G	D2723G	2723	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937507	A	T	Deleterious	1	c.8168A>T_p.Asp2723Val	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Likely_pathogenic		1	criteria_provided|_single_submitter	deleterious	0.935	26	5.384791	0.72958	0.55918	0.992325722	0.96247	-3.97	5.49	5.49	0.80903	0.84324	0	0.9839	0.9505	0.99706	1.1011	0.93054	3.38	0.81033	1	0.88722	0.67089	0.89267	0.92612	0.89865	1	0.97092	1	0.5723	-2.68	0.91219	0	0.75912	0.94854	0.952	0.708306	0.805605	rs41293513	NA	NA	NA	NA	NA	D2723V	c.8168A>T	D2723V	2723	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32937513	G	T	Deleterious	1	c.8174G>T_p.Trp2725Leu	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.886	28.4	6.142293	0.847	0.45371	0.98761058	0.84059	-1.82	5.49	5.49	0.80903	0.84324	0	0.94067	0.8234	0.95027	0.8496	0.9287	3.36	0.81033	1	0.7489	0.72479	0.61215	0.60462	0.89865	1	0.97092	1	0.7255	-3.87	0.91219	0	0.9435	0.81667	0.829	0.319415	0.31042	NA	NA	NA	NA	NA	NA	W2725L	c.8174G>T	W2725L	2725	Class C55	Deleterious	1	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32937516	A	G	Deleterious	1	c.8177A>G_p.Tyr2726Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_multiple_submitters|_no_conflicts	deleterious	0.911	25.8	5.307579	0.71803	0.77636	0.996592231	0.95426	-3.72	5.49	5.49	0.80903	0.84324	0	0.98137	0.9431	0.99525	1.0968	0.93145	3.39	0.58814	0.999999	0.60234	0.61045	0.89267	0.92612	0.89865	1	0.97092	1	0.5723	-2.68	0.91219	0	0.75912	0.88605	0.897	0.608262	0.676611	rs80359064	NA	NA	NA	NA	NA	Y2726C	c.8177A>G	Y2726C	2726	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937521	G	A	Neutral	0.002	c.8182G>A_p.Val2728Ile	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|ITMI|_University_of_Washington_Medical_Center|Pathway_Genomics|CSER_CC_NCGL|Counsyl|Invitae|GeneDx	hereditary_breast_and_ovarian_cancer|_BROVCA2|not_specified|Familial_cancer_of_breast|not_provided|AllHighlyPenetrant|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary|Not_specified|Hereditary_cancer-predisposing_syndrome|Breast_cancer|Breast-ovarian_cancer|_familial_2	Benign|Likely_benign			criteria_provided|_multiple_submitters|_no_conflicts	neutral	0	0.002	-1.847035	0.01016	0.00999	0.235190884	0.79956	-1.34	5.49	-7.77	0.01089	0.2496	0.032851	0.37561	0.1014	0.55513	-0.7942	0.00895	-1.11	0.08979	0.999991	0.3525	0.41043	0.19828	0.09022	0.02634	0	0.06334	0.002	0.07459	-0.03	0.00963	1	0.32193	0.79963	0.811	-0.109608	-0.0284956	rs28897749	245	1	216	2.03E-03	66738	V2728I	c.8182G>A	V2728I	2728	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32937526	G	T	Deleterious	0.999	c.8187G>T_p.Lys2729Asn	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|ITMI|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|not_specified|Familial_cancer_of_breast|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Uncertain_significance			reviewed_by_expert_panel	deleterious	0.469	23.1	3.52179	0.4809	0.31501	0.970283617	0.81655	-1.54	5.49	1.54	0.22086	0.35405	0.003106	0.79057	0.46	0.79767	-0.1149	0.53674	1.675	0.29766	0.735311	0.28778	0.40072	0.19984	0.06174	0.71542	0.998	0.64622	0.929	0.32773	-1.31	0.78421	0.001	0.52279	0.58035	0.543	-0.278029	-0.280156	rs80359065	100	NA	2	8.24E-04	66734	K2729N	c.8187G>T	K2729N	2729	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32937527	G	C	Deleterious	1	c.8188G>C_p.Ala2730Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Likely_pathogenic|Uncertain_significance		1	criteria_provided|_conflicting_interpretations	deleterious	0.849	26.3	5.539707	0.75308	0.8433	0.997538596	0.83507	-1.75	5.49	5.49	0.80903	0.84324	0	0.92771	0.7869	0.93826	0.7525	0.91347	3.205	0.42619	0.995268	0.28816	0.4269	0.61215	0.60462	0.89865	1	0.87503	0.998	0.36166	-1.48	0.72092	0.002	0.9435	0.92855	0.935	0.536639	0.564602	rs80359066	NA	NA	NA	NA	NA	A2730P	c.8188G>C	A2730P	2730	Class C0	Deleterious	1	1	1	test	BRCA12_Funct	13	0.03	This Study
13	32937528	C	T	Deleterious	0.999	c.8189C>T_p.Ala2730Val	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.745	28.6	6.178107	0.85236	0.971	0.998993488	0.8209	-1.59	5.49	5.49	0.80903	0.84324	0	0.86487	0.617	0.86831	0.2548	0.6743	2.05	0.38611	0.967787	0.2857	0.44245	0.4006	0.44667	0.67003	0.996	0.58559	0.844	0.30333	-1.19	0.31341	0.094	0.55995	0.85341	0.866	0.292388	0.201748	rs80359067	NA	NA	NA	NA	NA	A2730V	c.8189C>T	A2730V	2730	Class C0	Intermediate	0	1	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32937537	A	T	Deleterious	1	c.8198A>T_p.Asp2733Val	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.881	26.5	5.61131	0.76405	0.52677	0.991238483	0.88548	-2.41	5.49	5.49	0.80903	0.84324	0	0.95548	0.8661	0.96718	0.971	0.93189	3.395	0.81033	1	0.26341	0.52366	0.89267	0.92612	0.89865	1	0.97092	1	0.5723	-2.68	0.91219	0	0.75912	0.90248	0.912	0.544577	0.599105	NA	NA	NA	NA	NA	NA	D2733V	c.8198A>T	D2733V	2733	Class C65	Intermediate	0	1	1	test	BRCA12_Funct	13	0.81	This Study
13	32937572	C	G	Deleterious	0.999	c.8233C>G_p.Leu2745Val	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.772	24.1	4.38388	0.58688	0.79472	0.996870859	0.85553	-2.02	5.49	1.28	0.20465	0.5373	0.000053	0.90823	0.7316	0.83265	0.0507	0.85563	2.765	0.18878	0.999965	0.38722	0.26339	0.15121	0.08317	0.89865	1	0.91584	0.999	0.24025	-0.89	0.91219	0	0.46552	0.6799	0.67	0.114735	0.0211188	NA	NA	NA	NA	NA	NA	L2745V	c.8233C>G	L2745V	2745	Class C15	Neutral	0	0	1	train	BRCA12_Funct	13	0.29	This Study
13	32937582	G	A	Deleterious	1	c.8243G>A_p.Gly2748Asp	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Pathogenic|Uncertain_significance		1	reviewed_by_expert_panel	deleterious	0.897	31	6.578398	0.90463	0.84566	0.997564285	0.94166	-3.38	5.42	5.42	0.78533	0.84324	0	0.97532	0.9253	0.98459	1.0649	0.93189	3.395	0.81033	1	0.58582	0.39434	0.61215	0.60462	0.89865	1	0.97092	1	0.47479	-2.08	0.91219	0	0.93686	0.85854	0.871	0.505363	0.537663	rs80359071	NA	NA	NA	NA	NA	G2748D	c.8243G>A	G2748D	2748	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32937609	A	T	Deleterious	1	c.8270A>T_p.Glu2757Val	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.8	29.9	6.463786	0.89158	0.67943	0.995034833	0.8209	-1.59	5.42	5.42	0.78533	0.84324	0	0.90331	0.718	0.91223	0.5489	0.80931	2.52	0.58814	0.999997	0.88722	0.90892	0.89267	0.92612	0.89865	1	0.81812	0.995	0.47479	-2.08	0.91219	0	0.7483	0.72175	0.722	0.180025	0.109684	NA	NA	NA	NA	NA	NA	E2757V	c.8270A>T	E2757V	2757	Class C35	Neutral	0	0	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32937633	G	A	Deleterious	1	c.8294G>A_p.Cys2765Tyr	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.856	29.9	6.460852	0.89121	0.82906	0.997344119	0.81081	-1.47	5.56	5.56	0.83574	0.84324	0	0.9108	0.7388	0.92129	0.6174	0.8871	2.98	0.81033	1	0.65233	0.63571	0.61215	0.60462	0.89865	1	0.97092	1	0.65469	-3.27	0.91219	0	0.95091	0.80997	0.822	0.273112	0.24422	rs112343538	NA	NA	NA	NA	NA	C2765Y	c.8294G>A	C2765Y	2765	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	This Study
13	32937642	T	A	Deleterious	1	c.8303T>A_p.Leu2768His	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.859	29.7	6.412131	0.88513	0.3668	0.979635763	0.83085	-1.7	5.68	5.68	0.87945	0.62918	6.00E-06	0.91784	0.7587	0.93162	0.6987	0.88842	2.99	0.58814	0.999998	0.88722	0.7879	0.80647	0.76621	0.89865	1	0.97092	1	0.46468	-2.02	0.91219	0	0.79266	0.76344	0.771	0.232796	0.183278	rs587782732	NA	NA	NA	NA	NA	L2768H	c.8303T>A	L2768H	2768	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32937642	T	C	Deleterious	1	c.8303T>C_p.Leu2768Pro	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.882	28.7	6.215487	0.85793	0.97405	0.999024088	0.8317	-1.71	5.68	5.68	0.87945	0.62918	6.00E-06	0.92581	0.7815	0.94238	0.7857	0.92637	3.335	0.81033	1	0.88722	0.7879	0.80647	0.76621	0.89865	1	0.97092	1	0.46972	-2.05	0.91219	0	0.79266	0.84226	0.855	0.339807	0.329449	NA	NA	NA	NA	NA	NA	L2768P	c.8303T>C	L2768P	2768	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	This Study
13	32944549	A	T	Deleterious	1	c.8342A>T_p.Asn2781Ile	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.892	31	6.538471	0.90028	0.51106	0.990621366	0.87685	-2.3	5.33	5.33	0.75532	0.84324	0	0.94495	0.8355	0.95727	0.9036	0.93054	3.38	0.81033	1	0.60234	0.90892	0.85084	0.92612	0.89865	1	0.97092	1	0.5723	-2.68	0.91219	0	0.73582	0.83825	0.851	0.36703	0.370852	NA	NA	NA	NA	NA	NA	N2781I	c.8342A>T	N2781I	2781	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	This Study
13	32944552	G	A	Deleterious	0.999	c.8345G>A_p.Ser2782Asn	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.75	31	6.559596	0.90262	0.77003	0.996489461	0.81249	-1.49	5.33	5.33	0.75532	0.84324	0	0.90335	0.7181	0.9142	0.5636	0.86111	2.8	0.81033	1	0.55106	0.67089	0.53296	0.60462	0.89865	1	0.97092	1	0.24025	-0.89	0.91219	0	0.92877	0.61285	0.584	0.0231363	-0.081077	NA	1	NA	1	8.24E-06	66736	S2782N	c.8345G>A	S2782N	2782	Class C45	Neutral	0	0	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32944557	C	T	Deleterious	1	c.8350C>T_p.Arg2784Trp	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.886	35	7.961956	0.95643	0.97857	0.999092048	0.83425	-1.74	5.33	4.48	0.53723	0.84324	0	0.92121	0.7683	0.93776	0.7484	0.91136	3.185	0.58814	0.999994	0.40109	0.45737	0.12426	0.13381	0.89865	1	0.97092	1	0.52409	-2.38	0.91219	0	0.75958	0.82931	0.842	0.3095	0.272149	rs80359075	1	NA	1	8.24E-06	66740	R2784W	c.8350C>T	R2784W	2784	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32944558	G	A	Deleterious	1	c.8351G>A_p.Arg2784Gln	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|CSER_CC_NCGL|_University_of_Washington_Medical_Center|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Breast_cancer|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.82	35	8.07462	0.95701	0.99913	0.999471556	0.82361	-1.62	5.33	5.33	0.75532	0.84324	0	0.91327	0.7457	0.91925	0.6015	0.83251	2.635	0.58814	0.999999	0.39418	0.4664	0.53296	0.60462	0.89865	1	0.91584	0.999	0.30333	-1.19	0.91219	0	0.92877	0.93789	0.943	0.291469	0.570702	rs80359076	1	NA	NA	8.24E-06	66740	R2784Q	c.8351G>A	R2784Q	2784	Class C35	Deleterious	1	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2013
13	32944563	G	C	Deleterious	1	c.8356G>C_p.Ala2786Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.87	26.8	5.706095	0.77875	0.75331	0.996229602	0.84854	-1.93	5.19	4.35	0.51198	0.4374	0.000516	0.92962	0.7923	0.94093	0.774	0.91347	3.205	0.48225	0.999672	0.32179	0.72479	0.16653	0.60462	0.89865	1	0.8318	0.996	0.36361	-1.49	0.72092	0.002	0.6294	0.81379	0.826	0.302712	0.299188	rs80359077	NA	NA	NA	NA	NA	A2786P	c.8356G>C	A2786P	2786	Class C0	Deleterious	1	1	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32944566	C	T	Neutral	0.54	c.8359C>T_p.Arg2787Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	neutral	0.012	12.89	1.420505	0.23367	0.05847	0.584101591	0.81573	-1.53	5.19	-8.51	0.00804	0.31133	0.007869	0.64589	0.2739	0.41573	-0.9466	0.45843	1.435	0.42547	0.995095	0.29694	0.72479	0.00786	0.14223	0.29385	0.246	0.23873	0.05	0.11746	-0.29	0.10162	0.409	0.57748	0.57714	0.539	-0.165854	-0.361736	rs41293517	NA	NA	NA	NA	NA	R2787C	c.8359C>T	R2787C	2787	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32944567	G	A	Neutral	0.791	c.8360G>A_p.Arg2787His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Familial_cancer_of_breast	Uncertain_significance			criteria_provided|_single_submitter	neutral	0.071	27.3	5.845991	0.80074	0.63687	0.994256719	0.80997	-1.46	5.19	5.19	0.71253	0.31133	0.007869	0.86281	0.6121	0.84614	0.1241	0.56496	1.775	0.58814	0.999995	0.35124	0.72479	0.53296	0.60462	0.89865	1	0.65531	0.937	0.25766	-0.97	0.36462	0.064	0.91633	0.67126	0.659	-0.148173	-0.0483004	rs80359078	4	NA	2	3.30E-05	66740	R2787H	c.8360G>A	R2787H	2787	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32944569	T	C	Deleterious	1	c.8362T>C_p.Trp2788Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.945	28	6.045993	0.83214	0.79404	0.996853519	0.81164	-1.48	5.19	5.19	0.71253	0.84324	0	0.91141	0.7405	0.93181	0.7002	0.92403	3.31	0.81033	1	0.44841	0.72479	0.56393	0.76621	0.89865	1	0.97092	1	0.75338	-4.16	0.91219	0	0.71487	0.82931	0.842	0.299263	0.27458	rs80359079	NA	NA	NA	NA	NA	W2788R	c.8362T>C	W2788R	2788	Class C25	Deleterious	1	1	1	test	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32944570	G	C	Deleterious	1	c.8363G>C_p.Trp2788Ser	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.935	32	6.763522	0.92187	0.47062	0.988621321	0.81164	-1.48	5.19	5.19	0.71253	0.84324	0	0.91696	0.7562	0.93285	0.7085	0.92403	3.31	0.81033	1	0.48838	0.72479	0.53296	0.60462	0.89865	1	0.97092	1	0.75338	-4.16	0.91219	0	0.91633	0.79777	0.809	0.259252	0.225757	rs80359080	NA	NA	NA	NA	NA	W2788S	c.8363G>C	W2788S	2788	Class C35	Deleterious	1	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32944582	T	C	Deleterious	1	c.8375T>C_p.Leu2792Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.945	28.9	6.252121	0.86323	0.96869	0.99895802	0.93887	-3.32	5.19	5.19	0.71253	0.62918	2.00E-06	0.97165	0.9144	0.98291	1.0578	0.9287	3.36	0.81033	1	0.60234	0.5166	0.56393	0.76621	0.89865	1	0.97092	1	0.47479	-2.08	0.91219	0	0.71487	0.92855	0.935	0.662	0.743581	rs28897751	NA	NA	NA	NA	NA	L2792P	c.8375T>C	L2792P	2792	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32944584	G	A	Deleterious	1	c.8377G>A_p.Gly2793Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Likely_pathogenic|Pathogenic|Uncertain_significance		1	criteria_provided|_conflicting_interpretations	deleterious	0.945	33	6.949715	0.93443	0.99795	0.999414248	0.97129	-4.28	5.19	5.19	0.71253	0.84324	0	0.98753	0.9612	0.99718	1.1014	0.92917	3.365	0.81033	1	0.65233	0.50432	0.53296	0.60462	0.89865	1	0.97092	1	0.52409	-2.38	0.91219	0	0.91633	0.94616	0.95	0.468539	0.808511	rs80359082	1	NA	NA	8.24E-06	66740	G2793R	c.8377G>A	G2793R	2793	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32944585	G	A	Deleterious	1	c.8378G>A_p.Gly2793Glu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.945	31	6.600769	0.90698	0.85547	0.997685241	0.97105	-4.27	5.19	5.19	0.71253	0.84324	0	0.98753	0.9612	0.99718	1.1014	0.92917	3.365	0.81033	1	0.69624	0.50432	0.53296	0.60462	0.89865	1	0.97092	1	0.52409	-2.38	0.91219	0	0.91633	0.88389	0.895	0.615392	0.686023	rs80359083	NA	NA	NA	NA	NA	G2793E	c.8378G>A	G2793E	2793	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32944589	C	G	Deleterious	1	c.8382C>G_p.Phe2794Leu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.791	32	6.713742	0.91772	0.96792	0.998946678	0.80399	-1.39	5.19	5.19	0.71253	0.62918	1.00E-06	0.84557	0.5725	0.87859	0.3187	0.64725	1.99	0.33082	0.666198	0.88722	0.55026	0.34357	0.44667	0.89865	1	0.81812	0.995	0.4197	-1.78	0.72092	0.002	0.22408	0.74866	0.754	0.179457	0.0497421	rs80359084	1	NA	1	8.24E-06	66740	F2794L	c.8382C>G	F2794L	2794	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32944600	C	T	Deleterious	1	c.8393C>T_p.Pro2798Leu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.892	33	7.06193	0.94001	0.98436	0.999162072	0.80226	-1.37	5.19	5.19	0.71253	0.84324	0	0.90859	0.7326	0.92289	0.6297	0.88505	2.965	0.81033	1	0.65233	0.48486	0.34357	0.44667	0.89865	1	0.97092	1	0.61818	-2.97	0.91219	0	0.91633	0.69099	0.684	0.140903	0.0643883	rs276174906	NA	NA	NA	NA	NA	P2798L	c.8393C>T	P2798L	2798	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	This Study
13	32944605	C	T	Deleterious	1	c.8398C>T_p.Pro2800Ser	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.895	33	6.865428	0.9293	0.97176	0.99899565	0.80658	-1.42	5.19	5.19	0.71253	0.84324	0	0.90269	0.7163	0.91647	0.5806	0.84882	2.725	0.81033	1	0.69624	0.57508	0.34357	0.44667	0.89865	1	0.97092	1	0.52409	-2.38	0.91219	0	0.91633	0.69818	0.693	0.152351	0.0779864	rs80359086	NA	NA	NA	NA	NA	P2800S	c.8398C>T	P2800S	2800	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32944606	C	A	Deleterious	1	c.8399C>A_p.Pro2800His	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.919	33	6.989681	0.93659	0.70658	0.995474399	0.80912	-1.45	5.19	5.19	0.71253	0.84324	0	0.90287	0.7168	0.91779	0.5906	0.84882	2.725	0.81033	1	0.69624	0.57508	0.34357	0.44667	0.89865	1	0.97092	1	0.5723	-2.68	0.91219	0	0.91633	0.71355	0.712	0.18428	0.124792	NA	NA	NA	NA	NA	NA	P2800H	c.8399C>A	P2800H	2800	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32944606	C	G	Deleterious	1	c.8399C>G_p.Pro2800Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.919	30	6.48328	0.89393	0.94772	0.998706775	0.80743	-1.43	5.19	5.19	0.71253	0.84324	0	0.90287	0.7168	0.91779	0.5906	0.84882	2.725	0.81033	1	0.69624	0.57508	0.34357	0.44667	0.89865	1	0.97092	1	0.5723	-2.68	0.91219	0	0.91633	0.74523	0.75	0.210209	0.158434	rs80359087	NA	NA	NA	NA	NA	P2800R	c.8399C>G	P2800R	2800	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32944627	C	T	Deleterious	0.998	c.8420C>T_p.Ser2807Leu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_multiple_submitters|_no_conflicts	deleterious	0.793	34	7.418804	0.95066	0.98643	0.999194749	0.74591	-0.87	5.19	5.19	0.71253	0.5373	0.000047	0.84525	0.5718	0.85495	0.1752	0.65543	2.005	0.58814	0.999997	0.56092	0.67089	0.33676	0.44667	0.89865	1	0.97092	1	0.38897	-1.62	0.78421	0.001	0.91633	0.71683	0.716	-0.092993	-0.0046396	rs55763607	3	NA	NA	2.47E-05	66740	S2807L	c.8420C>T	S2807L	2807	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32944635	A	G	Neutral	0.956	c.8428A>G_p.Ser2810Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.589	25.6	5.235388	0.70725	0.85049	0.997622841	0.7202	-0.63	5.19	2.71	0.30842	0.62918	9.00E-06	0.52931	0.1816	0.61043	-0.6877	0.2577	0.755	0.32832	0.637976	0.88722	0.90892	0.80647	0.92612	0.28115	0.204	0.20829	0.032	0.24025	-0.89	0.38359	0.055	0.3904	0.7038	0.7	-0.0173741	-0.165598	rs80359089	1	NA	1	8.24E-06	66738	S2810G	c.8428A>G	S2810G	2810	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32944642	G	A	Deleterious	1	c.8435G>A_p.Gly2812Glu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.906	31	6.587425	0.90558	0.84886	0.997606607	0.9348	-3.24	5.19	5.19	0.71253	0.84324	0	0.9602	0.8801	0.96517	0.958	0.66975	2.045	0.81033	1	0.88722	0.72479	0.43686	0.60462	0.89865	1	0.97092	1	0.47984	-2.11	0.91219	0	0.91633	0.93438	0.94	0.647141	0.718245	rs80359091	NA	NA	NA	NA	NA	G2812E	c.8435G>A	G2812E	2812	Class C65	Intermediate	0	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32944645	G	A	Deleterious	0.999	c.8438G>A_p.Gly2813Glu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.812	31	6.584363	0.90526	0.8433	0.997534996	0.9348	-3.24	5.19	5.19	0.71253	0.84324	0	0.9602	0.8801	0.96517	0.958	0.66975	2.045	0.81033	1	0.88722	0.90892	0.43686	0.60462	0.89865	1	0.91584	0.999	0.47984	-2.11	0.91219	0	0.91633	0.94497	0.949	0.653517	0.726504	rs80359092	NA	NA	NA	NA	NA	G2813E	c.8438G>A	G2813E	2813	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32944650	G	A	Deleterious	0.999	c.8443G>A_p.Val2815Ile	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.713	26.7	5.665601	0.77243	0.88904	0.99805318	0.75677	-0.97	5.19	4.35	0.51198	0.84324	0	0.73231	0.3735	0.72846	-0.3744	0.52876	1.655	0.47381	0.999511	0.65233	0.90892	0.43686	0.60462	0.61549	0.99	0.49882	0.629	0.11203	-0.26	0.91219	0	0.62477	0.65644	0.64	-0.0262873	-0.173045	rs80359093	NA	NA	NA	NA	NA	V2815I	c.8443G>A	V2815I	2815	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32944654	G	A	Deleterious	1	c.8447G>A_p.Gly2816Asp	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.897	26.2	5.496845	0.74654	0.74725	0.996126735	0.73426	-0.76	5.19	2.41	0.28406	0.55863	0.000038	0.82753	0.534	0.83626	0.0699	0.65543	2.005	0.45633	0.998884	0.44646	0.72479	0.43686	0.60462	0.89865	1	0.71731	0.975	0.43301	-1.85	0.91219	0	0.81117	0.85341	0.866	0.213838	0.148517	rs56096120	NA	NA	NA	NA	NA	G2816D	c.8447G>A	G2816D	2816	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	This Study
13	32944669	T	C	Deleterious	0.999	c.8462T>C_p.Ile2821Thr	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.474	25.2	5.034202	0.67774	0.62723	0.994053837	0.72686	-0.69	5.19	5.19	0.71253	0.23982	0.041017	0.67597	0.3049	0.64521	-0.6078	0.40703	1.245	0.18203	0.999983	0.33712	0.5166	0.52916	0.76621	0.40791	0.733	0.45067	0.474	0.29104	-1.13	0.78421	0.001	0.71487	0.74609	0.751	0.0729054	-0.0265066	rs80359096	NA	NA	NA	NA	NA	I2821T	c.8462T>C	I2821T	2821	Class C25	Neutral	0	0	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32944677	A	G	Deleterious	1	c.8470A>G_p.Arg2824Gly	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.869	27.6	5.927965	0.81365	0.80569	0.997022921	0.79387	-1.28	5.19	4.02	0.45701	0.84324	0	0.86565	0.6189	0.86717	0.248	0.66975	2.045	0.5297	0.999963	0.34234	0.63571	0.80647	0.92612	0.89865	1	0.91584	0.999	0.43301	-1.85	0.91219	0	0.51742	0.92855	0.935	0.471777	0.488205	NA	NA	NA	NA	NA	NA	R2824G	c.8470A>G	R2824G	2824	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32945108	T	C	Neutral	0.957	c.8503T>C_p.Ser2835Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|ITMI|Pathway_Genomics|GeneDx|Counsyl|Invitae	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|not_specified|Familial_cancer_of_breast|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Not_specified|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2	Benign|Likely_benign			criteria_provided|_multiple_submitters|_no_conflicts	neutral	0.423	12.2	1.286741	0.21919	0.18925	0.902357221	0.52878	0.64	5.1	-5.84	0.0212	0.12462	0.454122	0.15769	0.0366	0.18001	-1.0377	0.11173	0.095	0.08979	1	0.28038	0.32039	0.05347	0.02535	0.15063	0.012	0.16611	0.016	0.22945	-0.84	0.14328	0.303	0.27672	0.6152	0.587	-0.492261	-0.547632	rs11571746	88	NA	6	7.25E-04	66678	S2835P	c.8503T>C	S2835P	2835	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32945115	G	A	Deleterious	1	c.8510G>A_p.Gly2837Glu	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.859	32	6.66213	0.91306	0.82475	0.997293786	0.90344	-2.67	5.1	5.1	0.6873	0.84324	0	0.94573	0.8377	0.94762	0.8282	0.72894	2.215	0.58814	0.999996	0.51013	0.57508	0.41381	0.60462	0.89865	1	0.91584	0.999	0.52409	-2.38	0.91219	0	0.90841	0.79499	0.806	0.321569	0.292741	NA	NA	NA	NA	NA	NA	G2837E	c.8510G>A	G2837E	2837	Class C65	Intermediate	0	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32945129	C	T	Deleterious	1	c.8524C>T_p.Arg2842Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.882	35	8.141353	0.95731	0.97328	0.999022445	0.84498	-1.88	5.1	5.1	0.6873	0.62918	3.00E-06	0.91675	0.7556	0.92652	0.6583	0.74251	2.255	0.81033	1	0.88722	0.7879	0.32744	0.44667	0.89865	1	0.97092	1	0.52409	-2.38	0.91219	0	0.90844	0.96543	0.966	0.556231	0.569279	rs80359104	NA	NA	NA	NA	NA	R2842C	c.8524C>T	R2842C	2842	Class C65	Intermediate	0	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32945130	G	A	Deleterious	1	c.8525G>A_p.Arg2842His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Benign|Likely_benign|Uncertain_significance			reviewed_by_expert_panel	deleterious	0.85	35	7.625757	0.95374	0.98843	0.999224855	0.84498	-1.88	5.1	5.1	0.6873	0.62918	3.00E-06	0.91675	0.7556	0.92652	0.6583	0.74251	2.255	0.81033	1	0.7489	0.67089	0.41381	0.60462	0.89865	1	0.97092	1	0.36361	-1.49	0.91219	0	0.90841	0.93088	0.937	0.344934	0.593324	rs80359105	7	NA	1	5.76E-05	66684	R2842H	c.8525G>A	R2842H	2842	Class C25	Intermediate	0	1	1	test	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32945130	G	C	Deleterious	1	c.8525G>C_p.Arg2842Pro	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.886	34	7.425998	0.9508	0.79742	0.996907026	0.84498	-1.88	5.1	5.1	0.6873	0.62918	3.00E-06	0.91675	0.7556	0.92652	0.6583	0.74251	2.255	0.81033	1	0.7489	0.67089	0.41381	0.60462	0.89865	1	0.97092	1	0.47479	-2.08	0.91219	0	0.90841	0.99915	0.997	0.556233	0.60749	NA	NA	NA	NA	NA	NA	R2842P	c.8525G>C	R2842P	2842	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32945130	G	T	Deleterious	1	c.8525G>T_p.Arg2842Leu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_multiple_submitters|_no_conflicts	deleterious	0.84	34	7.538191	0.95263	0.90775	0.998260517	0.84427	-1.87	5.1	5.1	0.6873	0.62918	3.00E-06	0.91658	0.7551	0.92531	0.6488	0.74251	2.255	0.81033	1	0.7489	0.67089	0.41381	0.60462	0.89865	1	0.97092	1	0.47479	-2.08	0.91219	0	0.90841	0.98244	0.98	0.543155	0.586759	rs80359105	1	NA	1	8.24E-06	66684	R2842L	c.8525G>T	R2842L	2842	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32945144	G	A	Deleterious	1	c.8539G>A_p.Glu2847Lys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.811	34	7.289778	0.94779	0.99034	0.999252509	0.82998	-1.69	5.1	5.1	0.6873	0.84324	0	0.90338	0.7182	0.91273	0.5527	0.74251	2.255	0.81033	1	0.65233	0.57508	0.41381	0.60462	0.89865	1	0.97092	1	0.30333	-1.19	0.91219	0	0.90841	0.87638	0.888	0.417999	0.422674	rs80359108	1	NA	1	8.24E-06	66686	E2847K	c.8539G>A	E2847K	2847	Class C55	Deleterious	1	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32945147	G	C	Deleterious	0.984	c.8542G>C_p.Glu2848Gln	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.69	29.1	6.29548	0.86939	0.89264	0.998098494	0.64463	-0.11	5.1	5.1	0.6873	0.62918	0.000015	0.77948	0.4413	0.80238	-0.0945	0.72894	2.215	0.54846	0.999987	0.7489	0.67089	0.41381	0.60462	0.89865	1	0.87503	0.998	0.24025	-0.89	0.91219	0	0.90841	0.68543	0.677	0.0282367	-0.0777452	rs587781893	NA	NA	NA	NA	NA	E2848Q	c.8542G>C	E2848Q	2848	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32945150	A	G	Deleterious	0.999	c.8545A>G_p.Lys2849Glu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.676	27.3	5.85234	0.8017	0.94136	0.998636453	0.65022	-0.14	5.1	5.1	0.6873	0.33676	0.004491	0.71747	0.3541	0.66656	-0.5541	0.69842	2.125	0.25309	0.977065	0.88722	0.72479	0.64734	0.92612	0.6001	0.987	0.56844	0.811	0.30128	-1.18	0.72092	0.002	0.70093	0.67204	0.66	-0.0360967	-0.203064	rs80359109	NA	NA	NA	NA	NA	K2849E	c.8545A>G	K2849E	2849	Class C15	Neutral	0	0	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32945157	C	T	Deleterious	0.999	c.8552C>T_p.Ala2851Val	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.678	34	7.25318	0.94681	0.98436	0.999168839	0.72686	-0.69	5.1	5.1	0.6873	0.62918	2.00E-06	0.83213	0.5436	0.84608	0.1238	0.74251	2.255	0.81033	1	0.62353	0.30549	0.32744	0.44667	0.89865	1	0.87503	0.998	0.30333	-1.19	0.91219	0	0.90844	0.79129	0.802	0.178074	0.103368	NA	NA	NA	NA	NA	NA	A2851V	c.8552C>T	A2851V	2851	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32945172	A	C	Deleterious	0.988	c.8567A>C_p.Glu2856Ala	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|not_specified|Familial_cancer_of_breast|not_provided|Not_specified|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Likely_benign			criteria_provided|_multiple_submitters|_no_conflicts	deleterious	0.724	28	6.035642	0.83059	0.62395	0.993984173	0.57277	0.4	5.28	5.28	0.7396	0.33614	0.004546	0.57267	0.2119	0.65107	-0.5935	0.34687	1.04	0.3468	0.814991	0.65233	0.29896	0.89267	0.92612	0.57749	0.981	0.6645	0.945	0.38514	-1.6	0.23416	0.163	0.48033	0.65566	0.639	-0.299041	-0.317346	rs11571747	107	NA	94	8.81E-04	66682	E2856A	c.8567A>C	E2856A	2856	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32945178	A	G	Deleterious	0.999	c.8573A>G_p.Gln2858Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|GeneDx|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.778	28.2	6.083377	0.83798	0.94592	0.998686158	0.6294	-0.02	5.28	5.28	0.7396	0.62918	4.00E-06	0.7622	0.4149	0.77438	-0.2097	0.69842	2.125	0.44437	0.998025	0.65233	0.37411	0.89267	0.92612	0.76378	0.999	0.75356	0.986	0.30333	-1.19	0.65363	0.004	0.72849	0.71847	0.718	0.0108556	-0.10051	rs80359114	2	NA	2	1.65E-05	66678	Q2858R	c.8573A>G	Q2858R	2858	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32945190	T	C	Deleterious	1	c.8585T>C_p.Leu2862Pro	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.879	31	6.564673	0.90319	0.96869	0.998962378	0.63931	-0.08	5.28	5.28	0.7396	0.42786	0.00064	0.76845	0.4242	0.79906	-0.1089	0.71587	2.175	0.81033	1	0.4721	0.72479	0.63346	0.76621	0.89865	1	0.85043	0.997	0.47479	-2.08	0.91219	0	0.72849	0.93438	0.94	0.421818	0.430096	NA	NA	NA	NA	NA	NA	L2862P	c.8585T>C	L2862P	2862	Class C45	Intermediate	0	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32945198	T	G	Deleterious	1	c.8593T>G_p.Leu2865Val	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Familial_cancer_of_breast	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.791	24.9	4.864391	0.65324	0.85801	0.997711038	0.81914	-1.57	5.28	-0.137	0.12707	0.48102	0.000191	0.85515	0.5942	0.81828	-0.0211	0.74251	2.255	0.4116	0.990431	0.41209	0.48075	0.63346	0.76621	0.71542	0.998	0.65419	0.936	0.24025	-0.89	0.91219	0	0.16887	0.77589	0.785	0.148395	0.0359763	rs80359117	NA	NA	NA	NA	NA	L2865V	c.8593T>G	L2865V	2865	Class C25	Neutral	0	0	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2013
13	32945223	T	G	Deleterious	1	c.8618T>G_p.Phe2873Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.859	29	6.278198	0.86695	0.47097	0.988645063	0.70843	-0.53	5.28	5.28	0.7396	0.84324	1.00E-06	0.8203	0.519	0.84445	0.1144	0.79985	2.48	0.50834	0.999903	0.35166	0.45199	0.63346	0.76621	0.89865	1	0.73244	0.98	0.51116	-2.3	0.91219	0	0.49818	0.76964	0.778	0.1574	0.0415021	rs80359120	NA	NA	NA	NA	NA	F2873C	c.8618T>G	F2873C	2873	Class C55	Neutral	0	0	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32950836	C	T	Neutral	0.907	c.8662C>T_p.Arg2888Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Benign|Likely_benign|Uncertain_significance			reviewed_by_expert_panel	deleterious	0.492	23.4	3.773407	0.51037	0.80777	0.997056335	0.70024	-0.46	5.32	4.48	0.53723	0.30526	0.009057	0.54839	0.1944	0.53698	-0.8242	0.54432	1.7	0.21632	0.999077	0.20623	0.08414	0.12254	0.14223	0.43605	0.816	0.29379	0.103	0.38707	-1.61	0.30055	0.103	0.62991	0.775	0.784	-0.173181	-0.101465	rs80359123	2	NA	NA	1.65E-05	66314	R2888C	c.8662C>T	R2888C	2888	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32950850	A	C	Deleterious	1	c.8676A>C_p.Arg2892Ser	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.811	23.9	4.264885	0.57124	0.85131	0.997634807	0.6135	0.1	5.32	4.16	0.47875	0.41322	0.000876	0.71639	0.3527	0.739	-0.3387	0.80931	2.52	0.37371	0.942634	0.38649	0.40185	0.19469	0.25406	0.89865	1	0.74543	0.984	0.36956	-1.52	0.6818	0.003	0.32246	0.79314	0.804	0.0949848	-0.0480519	NA	NA	NA	NA	NA	NA	R2892S	c.8676A>C	R2892S	2892	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32950867	T	C	Deleterious	1	c.8693T>C_p.Leu2898Ser	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.869	29	6.266601	0.86534	0.92866	0.998497288	0.7096	-0.54	5.32	5.32	0.75224	0.62918	2.00E-06	0.84389	0.5688	0.86793	0.2525	0.84368	2.695	0.51071	0.999919	0.55106	0.48486	0.38069	0.76621	0.89865	1	0.91584	0.999	0.37154	-1.53	0.91219	0	0.73342	0.73171	0.734	0.122361	0.0287346	rs28897752	NA	NA	NA	NA	NA	L2898S	c.8693T>C	L2898S	2898	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	This Study
13	32950876	G	A	Deleterious	1	c.8702G>A_p.Gly2901Asp	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.886	33	6.949193	0.93441	0.89174	0.998082714	0.77602	-1.12	5.32	5.32	0.75224	0.84324	0	0.88893	0.6788	0.90365	0.4868	0.85306	2.75	0.81033	1	0.88722	0.7879	0.37464	0.60462	0.89865	1	0.91584	0.999	0.4216	-1.79	0.91219	0	0.92761	0.94616	0.95	0.31294	0.538299	rs80359129	14	NA	NA	1.15E-04	66350	G2901D	c.8702G>A	G2901D	2901	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32950897	T	G	Deleterious	1	c.8723T>G_p.Val2908Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.859	28.1	6.063835	0.83496	0.7527	0.996215252	0.63589	-0.06	5.32	5.32	0.75224	0.52334	0.000071	0.7812	0.4441	0.8101	-0.0598	0.79985	2.48	0.58814	0.999994	0.52766	0.54028	0.38069	0.76621	0.89865	1	0.71274	0.973	0.40245	-1.69	0.91219	0	0.73342	0.87003	0.882	0.279845	0.191916	rs28897753	2	NA	2	1.65E-05	66052	V2908G	c.8723T>G	V2908G	2908	Class C35	Neutral	0	0	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2013
13	32950911	G	C	Deleterious	0.999	c.8737G>C_p.Asp2913His	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.677	32	6.77528	0.9228	0.75027	0.996183531	0.6804	-0.31	5.32	5.32	0.75224	0.84324	0	0.83199	0.5433	0.85903	0.1993	0.84882	2.725	0.58814	0.99999	0.45041	0.54028	0.37464	0.60462	0.89865	1	0.75356	0.986	0.41397	-1.75	0.91219	0	0.92761	0.74014	0.744	-0.113978	0.0343908	rs144322424	1	NA	NA	8.24E-06	65528	D2913H	c.8737G>C	D2913H	2913	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	This Study
13	32950912	A	G	Deleterious	0.999	c.8738A>G_p.Asp2913Gly	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.472	32	6.70019	0.9165	0.74845	0.996145957	0.67198	-0.26	5.32	5.32	0.75224	0.84324	0	0.81875	0.5158	0.84849	0.1376	0.84882	2.725	0.52429	0.999956	0.44455	0.51019	0.59756	0.92612	0.76378	0.999	0.73889	0.982	0.41778	-1.77	0.78421	0.001	0.73342	0.75644	0.763	0.109369	0.0115953	NA	NA	NA	NA	NA	NA	D2913G	c.8738A>G	D2913G	2913	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	This Study
13	32950913	C	G	Deleterious	0.999	c.8739C>G_p.Asp2913Glu	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	neutral	0.445	23.9	4.226862	0.56632	0.38747	0.982150505	0.65945	-0.19	5.32	0.635	0.16746	0.84324	0	0.57823	0.2161	0.58219	-0.7451	0.71587	2.175	0.36261	0.90528	0.42826	0.46325	0.12443	0.18684	0.52161	0.952	0.47361	0.549	0.24242	-0.9	0.41587	0.042	0.10611	0.65566	0.639	-0.12053	-0.298471	NA	NA	NA	NA	NA	NA	D2913E	c.8739C>G	D2913E	2913	Class C35	Neutral	0	0	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32953472	C	A	Deleterious	0.999	c.8773C>A_p.Gln2925Lys	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.742	33	6.973523	0.93573	0.63297	0.994177648	0.64648	-0.12	5.6	5.6	0.84902	0.84324	0	0.81418	0.5063	0.83236	0.0492	0.86111	2.8	0.58814	0.999996	0.7489	0.90892	0.48811	0.44667	0.89865	1	0.8318	0.996	0.30333	-1.19	0.91219	0	0.97286	0.75644	0.763	0.110302	0.010118	NA	NA	NA	NA	NA	NA	Q2925K	c.8773C>A	Q2925K	2925	Class C45	Deleterious	1	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32953473	A	G	Deleterious	0.999	c.8774A>G_p.Gln2925Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.778	28.5	6.165574	0.85048	0.93677	0.998584519	0.65022	-0.14	5.6	5.6	0.84902	0.84324	0	0.80308	0.4836	0.83727	0.0752	0.86111	2.8	0.53702	0.999976	0.88722	0.7879	0.95998	0.92612	0.89865	1	0.85043	0.997	0.30333	-1.19	0.91219	0	0.80669	0.73759	0.741	0.111554	0.0298991	rs80359135	NA	NA	NA	NA	NA	Q2925R	c.8774A>G	Q2925R	2925	Class C35	Intermediate	0	1	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32953474	G	C	Deleterious	1	c.8775G>C_p.Gln2925His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.848	26	5.394832	0.73108	0.84252	0.997523893	0.65945	-0.19	5.6	2.79	0.31541	0.84324	0	0.77116	0.4283	0.78581	-0.1643	0.86111	2.8	0.4532	0.998708	0.88722	0.72479	0.71188	0.22985	0.89865	1	0.87503	0.998	0.36361	-1.49	0.91219	0	0.41764	0.71191	0.71	0.0603212	-0.0637628	rs80359136	NA	NA	NA	NA	NA	Q2925H	c.8775G>C	Q2925H	2925	Class C15	Intermediate	0	1	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32953485	T	G	Deleterious	1	c.8786T>G_p.Leu2929Trp	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.879	28.1	6.066128	0.83529	0.28326	0.961628342	0.67198	-0.26	5.6	5.6	0.84902	0.84324	1.00E-06	0.82082	0.5201	0.84946	0.1432	0.83789	2.665	0.46368	0.999212	0.88722	0.72479	0.80647	0.76621	0.89865	1	0.97092	1	0.4197	-1.78	0.91219	0	0.80669	0.78947	0.8	0.165827	0.0892328	NA	NA	NA	NA	NA	NA	L2929W	c.8786T>G	L2929W	2929	Class C55	Neutral	0	0	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32953529	A	T	Deleterious	0.999	c.8830A>T_p.Ile2944Phe	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|ITMI|Pathway_Genomics|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Not_specified|not_specified|Familial_cancer_of_breast|not_provided|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Uncertain_significance			reviewed_by_expert_panel	neutral	0.459	25.5	5.209097	0.70341	0.3057	0.967965895	0.62785	-0.01	5.6	1.66	0.22872	0.35405	0.003108	0.37153	0.0998	0.55874	-0.788	0.80931	2.52	0.4482	0.998352	0.7489	0.43043	0.95998	0.17454	0.59616	0.986	0.56751	0.809	0.28897	-1.12	0.72092	0.002	0.07754	0.58995	0.555	-0.352992	-0.37755	rs4987047	442	7	2	3.77E-03	66376	I2944F	c.8830A>T	I2944F	2944	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32953538	G	A	Deleterious	1	c.8839G>A_p.Glu2947Lys	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.819	28.6	6.194189	0.85474	0.97405	0.999032421	0.60632	0.16	5.6	5.6	0.84902	0.62918	6.00E-06	0.75673	0.407	0.77846	-0.1938	0.81747	2.56	0.39609	0.979913	0.45249	0.40661	0.71188	0.60462	0.76378	0.999	0.69872	0.967	0.30333	-1.19	0.72092	0.002	0.85946	0.71683	0.716	0.0430536	-0.113206	NA	NA	NA	NA	NA	NA	E2947K	c.8839G>A	E2947K	2947	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32953549	G	T	Deleterious	1	c.8850G>T_p.Lys2950Asn	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|ITMI|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|not_specified|Familial_cancer_of_breast|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Not_specified|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2	Benign|Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.85	24	4.337743	0.58076	0.67021	0.994880102	0.63589	-0.06	5.6	1.76	0.23563	0.62918	9.00E-06	0.68835	0.3187	0.73659	-0.347	0.83251	2.635	0.4706	0.999434	0.41903	0.39536	0.08765	0.16496	0.89865	1	0.67081	0.95	0.35968	-1.47	0.78421	0.001	0.43487	0.59471	0.561	-0.326095	-0.339779	rs28897754	82	NA	54	6.75E-04	66378	K2950N	c.8850G>T	K2950N	2950	Class C35	Neutral	0	0	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32953550	G	A	Deleterious	1	c.8851G>A_p.Ala2951Thr	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|ITMI|Pathway_Genomics|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP)	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|not_specified|Familial_cancer_of_breast|not_provided|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign			criteria_provided|_multiple_submitters|_no_conflicts	deleterious	0.844	29.5	6.369753	0.87959	0.97707	0.999070134	0.68902	-0.37	5.6	5.6	0.84902	0.84324	0	0.60548	0.2378	0.76833	-0.2327	0.84882	2.725	0.58814	0.999999	0.41433	0.39335	0.71188	0.60462	0.89865	1	0.91584	0.999	0.30333	-1.19	0.91219	0	0.97286	0.72587	0.727	-0.068013	0.0176307	rs11571769	914	17	293	7.82E-03	66374	A2951T	c.8851G>A	A2951T	2951	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32953592	G	C	Deleterious	0.999	c.8893G>C_p.Asp2965His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	neutral	0.452	24.5	4.619647	0.61883	0.29426	0.964873201	0.71316	-0.57	5.6	4.76	0.59962	0.84324	0	0.81288	0.5036	0.85015	0.1471	0.84368	2.695	0.52429	0.999957	0.69624	0.34774	0.2142	0.60462	0.63734	0.993	0.56535	0.804	0.42352	-1.8	0.78421	0.001	0.71194	0.71355	0.712	0.0725394	-0.0645841	rs80359141	NA	NA	NA	NA	NA	D2965H	c.8893G>C	D2965H	2965	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32953596	T	C	Deleterious	1	c.8897T>C_p.Val2966Ala	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.801	25	4.948742	0.66537	0.83718	0.997451846	0.67884	-0.3	5.6	5.6	0.84902	0.84324	0	0.82588	0.5306	0.85588	0.1806	0.86111	2.8	0.58814	0.999991	0.7489	0.34452	0.80647	0.76621	0.89865	1	0.91584	0.999	0.30333	-1.19	0.91219	0	0.80669	0.81188	0.824	0.202487	0.137603	NA	NA	NA	NA	NA	NA	V2966A	c.8897T>C	V2966A	2966	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	This Study
13	32953604	G	A	Deleterious	0.999	c.8905G>A_p.Val2969Met	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|GeneDx|Counsyl|Invitae|Sharing_Clinical_Reports_Project_(SCRP)	not_specified|Familial_cancer_of_breast|Not_specified|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Likely_benign|Uncertain_significance			reviewed_by_expert_panel	deleterious	0.637	24.3	4.514222	0.6044	0.82762	0.997330619	0.74485	-0.86	5.46	0.674	0.16963	0.45965	0.000314	0.54824	0.1943	0.5846	-0.7404	0.81747	2.56	0.40625	0.987644	0.47504	0.42196	0.09124	0.60462	0.49712	0.929	0.29639	0.107	0.22729	-0.83	0.78421	0.001	0.21664	0.49973	0.446	-0.349612	-0.356329	rs59004709	49	NA	41	4.04E-04	66196	V2969M	c.8905G>A	V2969M	2969	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32953614	T	G	Deleterious	1	c.8915T>G_p.Leu2972Trp	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.911	26.7	5.660878	0.77169	0.27424	0.958560812	0.76568	-1.04	5.46	5.46	0.79898	0.5373	0.000057	0.87944	0.6535	0.89789	0.4467	0.82459	2.595	0.47023	0.999425	0.35041	0.2918	0.80647	0.76621	0.89865	1	0.97092	1	0.41778	-1.77	0.91219	0	0.78299	0.78765	0.798	-0.00905338	0.157681	rs80359142	8	NA	8	6.59E-05	66164	L2972W	c.8915T>G	L2972W	2972	Class C15	Intermediate	0	1	1	test	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32953616	C	T	Deleterious	1	c.8917C>T_p.Arg2973Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Benign|Likely_benign|Uncertain_significance			reviewed_by_expert_panel	deleterious	0.873	33	7.096894	0.94149	0.94411	0.998662884	0.74696	-0.88	5.46	4.61	0.56482	0.40729	0.001	0.83602	0.5518	0.85864	0.197	0.84154	2.685	0.40388	0.986157	0.29508	0.24598	0.48811	0.44667	0.89865	1	0.638	0.92	0.52409	-2.38	0.40524	0.046	0.47886	0.60025	0.568	-0.0339691	-0.217168	rs45469092	2	NA	2	1.65E-05	66140	R2973C	c.8917C>T	R2973C	2973	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32953617	G	A	Deleterious	1	c.8918G>A_p.Arg2973His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.849	33	6.864767	0.92924	0.98972	0.999245929	0.74485	-0.86	5.46	5.46	0.79898	0.40729	0.001	0.84439	0.5699	0.84242	0.1032	0.84154	2.685	0.29921	0.718689	0.27754	0.23807	0.71188	0.60462	0.89865	1	0.87503	0.998	0.36361	-1.49	0.63171	0.005	0.43507	0.60498	0.574	-0.267756	-0.19242	rs80359143	5	NA	3	4.12E-05	66134	R2973H	c.8918G>A	R2973H	2973	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32953640	G	A	Deleterious	0.99	c.8941G>A_p.Glu2981Lys	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|GeneDx|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|not_provided|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_multiple_submitters|_no_conflicts	neutral	0.406	25.5	5.19007	0.70058	0.57769	0.992872982	0.72793	-0.7	5.46	3.7	0.41339	0.31111	0.007912	0.71175	0.3468	0.80927	-0.0637	0.80931	2.52	0.31961	0.531586	0.26946	0.37411	0.71188	0.60462	0.47937	0.905	0.40124	0.325	0.25329	-0.95	0.57428	0.009	0.82472	0.69099	0.684	0.00746575	-0.120339	rs139052578	NA	NA	NA	NA	NA	E2981K	c.8941G>A	E2981K	2981	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32953895	A	G	NA		c.8962A>G_p.Ser2988Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided			26.8	5.693466	0.7768	0.75514	0.996262553	0.74696	-0.88	5.66	5.66	0.87211	0.55863	0.000023	0.8067	0.4909	0.84525	0.119	0.79762	2.47	0.40841	0.98885	0.41664	0.57508	0.95998	0.92612	0.65671	0.995	0.50184	0.638	0.25981	-0.98	0.72092	0.002	0.81699	0.71355	0.712	0.111874	0.0148635	rs80359147	NA	NA	NA	NA	NA	S2988G	c.8962A>G	S2988G	2988	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32953904	C	T	NA		c.8971C>T_p.Arg2991Cys	ENST00000380152	BRCA2	MODERATE	missense_variant									24.5	4.655443	0.62382	0.80499	0.99701091	0.74061	-0.82	5.66	3.94	0.44538	0.84324	0	0.71301	0.3484	0.75863	-0.2687	0.85306	2.75	0.81033	1	0.7489	0.90892	0.17034	0.44667	0.46956	0.89	0.33941	0.175	0.42543	-1.81	0.43035	0.037	0.5684	0.6152	0.587	-0.0807744	-0.236885	NA	1	NA	1	8.24E-06	66570	R2991C	c.8971C>T	R2991C	2991	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	This Study
13	32953905	G	A	NA		c.8972G>A_p.Arg2991His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario	not_specified|Familial_cancer_of_breast|Not_specified|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations			34	7.41201	0.95053	0.85213	0.99764489	0.73747	-0.79	5.66	4.81	0.61179	0.84324	0	0.72487	0.3637	0.79467	-0.1278	0.85306	2.75	0.53702	0.999977	0.88722	0.90892	0.71188	0.60462	0.5545	0.972	0.35156	0.2	0.31561	-1.25	0.72092	0.002	0.69351	0.65489	0.638	-0.231139	-0.158894	rs80359150	6	NA	1	4.94E-05	66576	R2991H	c.8972G>A	R2991H	2991	Class C25	Neutral	0	0	1	train	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32953937	G	A	NA		c.9004G>A_p.Glu3002Lys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_pathogenic|Pathogenic|Uncertain_significance		1	criteria_provided|_conflicting_interpretations			34	7.462608	0.95145	0.97556	0.999049384	0.76698	-1.05	5.66	5.66	0.87211	0.84324	0	0.89518	0.6958	0.90337	0.4849	0.86887	2.85	0.81033	1	0.65233	0.63571	0.71188	0.60462	0.89865	1	0.91584	0.999	0.27662	-1.06	0.91219	0	0.97912	0.93204	0.938	0.501562	0.543771	rs80359152	NA	NA	NA	NA	NA	E3002K	c.9004G>A	E3002K	3002	Class C55	Deleterious	1	1	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2013
13	32953939	A	T	NA		c.9006A>T_p.Glu3002Asp	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Likely_benign|Likely_pathogenic|Uncertain_significance	1	1	criteria_provided|_conflicting_interpretations			24.5	4.656602	0.62394	0.80222	0.996974674	0.77602	-1.12	5.66	-1.91	0.07177	0.84324	0	0.86227	0.6108	0.86038	0.2073	0.86887	2.85	0.43829	0.997351	0.55106	0.67089	0.04529	0.26168	0.89865	1	0.8318	0.996	0.21863	-0.79	0.91219	0	0.59304	0.77143	0.78	0.141982	0.0547971	rs80359153	NA	NA	NA	NA	NA	E3002D	c.9006A>T	E3002D	3002	Class C35	Intermediate	0	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2013
13	32953941	G	A	NA		c.9008G>A_p.Gly3003Glu	ENST00000380152	BRCA2	MODERATE	missense_variant									32	6.75186	0.92094	0.84021	0.997495409	0.80997	-1.46	5.66	5.66	0.87211	0.84324	0	0.90615	0.7258	0.91146	0.5431	0.86111	2.8	0.81033	1	0.69624	0.7879	0.71188	0.60462	0.89865	1	0.97092	1	0.47984	-2.11	0.91219	0	0.97912	0.8732	0.885	0.412563	0.427183	NA	NA	NA	NA	NA	NA	G3003E	c.9008G>A	G3003E	3003	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32953952	A	G	NA		c.9019A>G_p.Arg3007Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_multiple_submitters|_no_conflicts			26.4	5.565324	0.75699	0.88007	0.997956666	0.73319	-0.75	5.66	-0.229	0.1235	0.62918	5.00E-06	0.83965	0.5596	0.86732	0.2489	0.82459	2.595	0.3685	0.927258	0.34841	0.90892	0.2483	0.92612	0.89865	1	0.78197	0.991	0.43301	-1.85	0.78421	0.001	0.65919	0.77143	0.78	0.116068	0.0294668	rs397507417	NA	NA	NA	NA	NA	R3007G	c.9019A>G	R3007G	3007	Class C45	Intermediate	0	1	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32953965	T	C	NA		c.9032T>C_p.Leu3011Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations			28.1	6.056213	0.83375	0.95289	0.998764227	0.80658	-1.42	5.66	4.48	0.53723	0.51284	0.000094	0.8861	0.6712	0.89886	0.4531	0.8513	2.74	0.81033	1	0.88722	0.32991	0.80647	0.76621	0.89865	1	0.97092	1	0.41016	-1.73	0.78421	0.001	0.48501	0.92164	0.929	0.512405	0.516587	rs80359155	NA	NA	NA	NA	NA	L3011P	c.9032T>C	L3011P	3011	Class C25	Intermediate	0	1	1	test	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32953971	C	T	NA		c.9038C>T_p.Thr3013Ile	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|CSER_CC_NCGL|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|Biesecker_Laboratory_-_ClinSeq_Project|_NHGRI|_University_of_Washington_Medical_Center|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|not_specified|Familial_cancer_of_breast|not_provided|Not_specified|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Breast_cancer	Benign|Likely_benign			criteria_provided|_multiple_submitters|_no_conflicts			25.9	5.378562	0.72866	0.73056	0.99585374	0.72246	-0.65	5.66	3.91	0.44113	0.20101	0.095676	0.61038	0.2419	0.54901	-0.8046	0.56865	1.78	0.08979	1	0.45464	0.24668	0.18399	0.16496	0.46128	0.875	0.35532	0.208	0.22729	-0.83	0.43343	0.036	0.4971	0.82931	0.842	-0.059162	0.0288972	rs28897755	28	NA	24	2.31E-04	66098	T3013I	c.9038C>T	T3013I	3013	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32953992	C	G	NA		c.9059C>G_p.Ser3020Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided			24.6	4.699471	0.62992	0.25907	0.952470615	0.73531	-0.77	5.66	2.84	0.31989	0.22564	0.056224	0.79006	0.4591	0.69004	-0.4908	0.75435	2.3	0.08979	1	0.33449	0.27939	0.18399	0.16496	0.68941	0.997	0.57119	0.817	0.23156	-0.85	0.45705	0.029	0.3501	0.63003	0.606	-0.0910619	-0.276233	rs80359157	NA	NA	NA	NA	NA	S3020C	c.9059C>G	S3020C	3020	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32954009	C	G	NA		c.9076C>G_p.Gln3026Glu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter			27.1	5.794036	0.79254	0.60708	0.99361294	0.73002	-0.72	5.66	5.66	0.87211	0.62918	9.00E-06	0.76997	0.4265	0.80967	-0.0618	0.83421	2.645	0.58814	0.999996	0.25396	0.2282	0.48811	0.44667	0.56368	0.976	0.45241	0.479	0.20582	-0.73	0.72092	0.002	0.97912	0.68384	0.675	0.0355501	-0.0858214	rs80359159	2	NA	2	1.65E-05	64416	Q3026E	c.9076C>G	Q3026E	3026	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32954015	G	C	NA		c.9082G>C_p.Ala3028Pro	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter			26.2	5.479248	0.74385	0.46718	0.988427386	0.72134	-0.64	5.66	3.29	0.36538	0.43568	0.000539	0.48818	0.1561	0.45111	-0.9234	0.14743	0.345	0.24144	0.990446	0.28893	0.35012	0.11618	0.20659	0.31604	0.337	0.30869	0.123	0.19728	-0.69	0.72092	0.002	0.20423	0.67754	0.667	-0.0614545	-0.212162	rs80359161	NA	NA	NA	NA	NA	A3028P	c.9082G>C	A3028P	3028	Class C0	Deleterious	1	1	1	test	BRCA12_Funct	13	0.03	This Study
13	32954019	C	T	NA		c.9086C>T_p.Ala3029Val	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter			23.9	4.246521	0.5689	0.54506	0.991872661	0.75677	-0.97	5.66	4.81	0.61179	0.44304	0.000454	0.70163	0.3343	0.7519	-0.2933	0.83789	2.665	0.4569	0.998911	0.30096	0.3877	0.16444	0.15819	0.47101	0.892	0.20261	0.029	0.17635	-0.59	0.40019	0.048	0.89268	0.71601	0.715	-0.15741	-0.0744854	rs80359162	3	NA	NA	3.30E-05	64078	A3029V	c.9086C>T	A3029V	3029	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32954022	C	T	NA		c.9089C>T_p.Thr3030Ile	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter			32	6.7813	0.92328	0.96946	0.998970874	0.73531	-0.77	5.66	5.66	0.87211	0.84324	0	0.86349	0.6137	0.86395	0.2285	0.76816	2.35	0.81033	1	0.38945	0.48922	0.48811	0.44667	0.89865	1	0.91584	0.999	0.38125	-1.58	0.91219	0	0.97912	0.76257	0.77	0.153123	0.0719836	rs587781792	NA	NA	NA	NA	NA	T3030I	c.9089C>T	T3030I	3030	Class C65	Neutral	0	0	1	train	BRCA12_Funct	13	0.81	This Study
13	32954031	C	T	NA		c.9098C>T_p.Thr3033Ile	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter			33	7.06521	0.94016	0.95035	0.998736662	0.80313	-1.38	5.66	5.66	0.87211	0.84324	0	0.90561	0.7243	0.90727	0.5126	0.85306	2.75	0.81033	1	0.88722	0.72479	0.48811	0.44667	0.89865	1	0.97092	1	0.38125	-1.58	0.91219	0	0.97912	0.81475	0.827	0.266229	0.220078	rs431825374	NA	NA	NA	NA	NA	T3033I	c.9098C>T	T3033I	3033	Class C65	Intermediate	0	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32954037	A	C	NA		c.9104A>C_p.Tyr3035Ser	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|ITMI|GeneDx|Invitae|Sharing_Clinical_Reports_Project_(SCRP)	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|not_specified|Familial_cancer_of_breast|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations			27.9	6.017219	0.82768	0.50359	0.99029455	0.73958	-0.81	5.66	4.46	0.53315	0.55863	0.000034	0.84367	0.5683	0.85514	0.1763	0.82459	2.595	0.40955	0.989444	0.69624	0.61045	0.95998	0.92612	0.89865	1	0.75356	0.986	0.52409	-2.38	0.91219	0	0.42628	0.77143	0.78	-0.0544734	0.0566347	rs80359165	6	NA	5	4.94E-05	63424	Y3035S	c.9104A>C	Y3035S	3035	Class C55	Intermediate	0	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32954037	A	G	NA		c.9104A>G_p.Tyr3035Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|GeneDx|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			criteria_provided|_single_submitter			27.3	5.858854	0.80272	0.85213	0.997641579	0.74273	-0.84	5.66	4.46	0.53315	0.55863	0.000034	0.84367	0.5683	0.85514	0.1763	0.82459	2.595	0.41822	0.993048	0.69624	0.61045	0.95998	0.92612	0.89865	1	0.77437	0.99	0.52409	-2.38	0.91219	0	0.42628	0.75993	0.767	-0.055802	0.0537058	rs80359165	3	NA	NA	2.47E-05	63424	Y3035C	c.9104A>G	Y3035C	3035	Class C55	Neutral	0	0	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32954049	C	T	NA		c.9116C>T_p.Pro3039Leu	ENST00000380152	BRCA2	MODERATE	splice_region_variant|missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations			24.5	4.618517	0.61865	0.4179	0.985047113	0.72793	-0.7	5.66	3.91	0.44113	0.22083	0.062468	0.62328	0.253	0.62149	-0.6635	0.79985	2.48	0.81033	1	0.38795	0.30831	0.48811	0.44667	0.36903	0.579	0.20829	0.032	0.45913	-1.99	0.40019	0.048	0.26523	0.65022	0.632	-0.300954	-0.265948	rs80359167	10	NA	3	8.24E-05	62844	P3039L	c.9116C>T	P3039L	3039	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32954180	C	T	NA		c.9154C>T_p.Arg3052Trp	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Pathogenic|Uncertain_significance		1	reviewed_by_expert_panel			34	7.118822	0.94236	0.96406	0.998905083	0.87764	-2.31	5.5	1.4	0.21194	0.84324	0	0.91921	0.7626	0.91922	0.6013	0.79762	2.47	0.52429	0.999955	0.65233	0.35516	0.24632	0.22251	0.89865	1	0.97092	1	0.4714	-2.06	0.91219	0	0.57829	0.97032	0.97	0.425193	0.574442	rs45580035	1	NA	NA	8.24E-06	66406	R3052W	c.9154C>T	R3052W	3052	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32954198	A	G	NA		c.9172A>G_p.Ser3058Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided			8.015	0.579741	0.14941	0.43228	0.986143585	0.82001	-1.58	5.5	-1.81	0.07406	0.07874	0.987433	0.68713	0.3173	0.52734	-0.8391	0.30057	0.895	0.08979	0.99999	0.46156	0.13366	0.26212	0.26168	0.11171	0.004	0.09293	0.004	0.21008	-0.75	0.24625	0.15	0.18358	0.67204	0.66	-0.0484122	-0.192943	rs80359173	NA	NA	NA	NA	NA	S3058G	c.9172A>G	S3058G	3058	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32954213	C	T	NA		c.9187C>T_p.Pro3063Ser	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Molecular_Genetics_Diagnostic_Laboratory|Children's_Hospital_of_Eastern_Ontario|Invitae	not_specified|Not_specified|Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided			24.1	4.407117	0.59	0.97481	0.999037912	0.80486	-1.4	5.5	4.66	0.5762	0.84324	0	0.69754	0.3294	0.71411	-0.4201	0.4173	1.285	0.50622	0.999896	0.50054	0.16321	0.48811	0.44667	0.4153	0.759	0.36348	0.226	0.43683	-1.87	0.39285	0.051	0.46293	0.67754	0.667	-0.208709	-0.138791	rs80359176	6	NA	6	4.94E-05	66612	P3063S	c.9187C>T	P3063S	3063	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32954231	T	C	NA		c.9205T>C_p.Cys3069Arg	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics	Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter			27.5	5.912961	0.81126	0.40212	0.983661341	0.81914	-1.57	5.5	5.5	0.81269	0.55863	0.000024	0.89427	0.6933	0.90419	0.4905	0.76554	2.34	0.81033	1	0.65233	0.37629	0.80647	0.76621	0.89865	1	0.66952	0.949	0.51278	-2.31	0.91219	0	0.79003	0.71519	0.714	0.167989	0.0355938	NA	1	NA	1	8.24E-06	66634	C3069R	c.9205T>C	C3069R	3069	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32954239	G	T	NA		c.9213G>T_p.Glu3071Asp	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided			27	5.750118	0.7856	0.8738	0.997893801	0.88782	-2.44	5.5	2.58	0.29767	0.84324	0	0.92916	0.791	0.91353	0.5586	0.83541	2.65	0.43304	0.996591	0.88722	0.5315	0.23978	0.19497	0.89865	1	0.91584	0.999	0.21647	-0.78	0.91219	0	0.34253	0.73843	0.742	0.217123	0.152288	rs80359184	NA	NA	NA	NA	NA	E3071D	c.9213G>T	E3071D	3071	Class C35	Neutral	0	0	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32954244	A	G	NA		c.9218A>G_p.Asp3073Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter			32	6.748503	0.92066	0.96094	0.998860236	0.91316	-2.84	5.5	5.5	0.81269	0.84324	0	0.95137	0.854	0.95763	0.9061	0.83541	2.65	0.81033	1	0.60234	0.40786	0.95998	0.92612	0.89865	1	0.97092	1	0.42543	-1.81	0.91219	0	0.79003	0.79592	0.807	0.360712	0.350392	rs80359186	1	NA	1	8.24E-06	66598	D3073G	c.9218A>G	D3073G	3073	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32954252	G	C	NA		c.9226G>C_p.Gly3076Arg	ENST00000380152	BRCA2	MODERATE	missense_variant									32	6.670516	0.91383	0.99434	0.999322921	0.94696	-3.51	5.5	5.5	0.81269	0.84324	0	0.97306	0.9186	0.97633	1.0254	0.83541	2.65	0.81033	1	0.62353	0.44704	0.71188	0.60462	0.89865	1	0.97092	1	0.47309	-2.07	0.91219	0	0.96265	0.84832	0.861	0.460889	0.482184	NA	NA	NA	NA	NA	NA	G3076V	c.9226G>C	G3076R	3076	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32954253	G	A	NA		c.9227G>A_p.Gly3076Glu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided			32	6.762546	0.92177	0.84174	0.997520378	0.94696	-3.51	5.5	5.5	0.81269	0.84324	0	0.97306	0.9186	0.97633	1.0254	0.83541	2.65	0.81033	1	0.58582	0.44704	0.71188	0.60462	0.89865	1	0.97092	1	0.47309	-2.07	0.91219	0	0.96265	0.86897	0.881	0.538564	0.584568	rs80359187	1	NA	1	8.24E-06	66562	G3076E	c.9227G>A	G3076E	3076	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32954253	G	T	NA		c.9227G>T_p.Gly3076Val	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter			31	6.59736	0.90662	0.8538	0.997659281	0.94731	-3.52	5.5	5.5	0.81269	0.84324	0	0.97306	0.9186	0.97633	1.0254	0.83541	2.65	0.81033	1	0.58582	0.44704	0.71188	0.60462	0.89865	1	0.97092	1	0.51605	-2.33	0.91219	0	0.96265	0.81571	0.828	0.427687	0.439152	rs80359187	NA	NA	NA	NA	NA	G3076R	c.9227G>T	G3076V	3076	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32954261	G	A	NA		c.9235G>A_p.Val3079Ile	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|ITMI|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|not_specified|Familial_cancer_of_breast|not_provided|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Likely_benign|Uncertain_significance			reviewed_by_expert_panel			13.44	1.523647	0.24517	0.29683	0.96558838	0.80912	-1.45	5.5	3.38	0.37542	0.84324	1.00E-06	0.57823	0.2161	0.55862	-0.7882	0.28332	0.835	0.29123	0.201841	0.35083	0.49388	0.09261	0.22985	0.40163	0.712	0.31399	0.132	0.09644	-0.17	0.06094	0.574	0.23339	0.57311	0.534	-0.29358	-0.345057	rs55933907	36	NA	3	2.97E-04	66454	V3079I	c.9235G>A	V3079I	3079	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32954268	T	C	NA		c.9242T>C_p.Val3081Ala	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations			27.7	5.960084	0.8187	0.96484	0.998908398	0.84569	-1.89	5.5	5.5	0.81269	0.55863	0.000022	0.89999	0.7089	0.94434	0.8017	0.80569	2.505	0.33003	0.657481	0.60234	0.40661	0.80647	0.76621	0.61549	0.99	0.55999	0.793	0.27046	-1.03	0.78421	0.001	0.79003	0.73674	0.74	0.145898	0.0869049	rs80359189	2	NA	2	1.65E-05	66318	V3081A	c.9242T>C	V3081A	3081	Class C25	Neutral	0	0	1	test	BRCA12_Funct	13	0.29	Guidugli et. al, 2016
13	32968832	C	T	Neutral	0.974	c.9263C>T_p.Ala3088Val	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.65	23.1	3.504104	0.47884	0.96792	0.99895295	0.82361	-1.62	5.9	4.18	0.48211	0.28163	0.015692	0.69771	0.3296	0.64905	-0.5985	0.40703	1.245	0.28252	0.866344	0.40019	0.42196	0.48811	0.44667	0.40499	0.725	0.28162	0.088	0.28694	-1.11	0.39048	0.052	0.45818	0.72257	0.723	0.0836411	-0.0523637	rs80359193	NA	NA	NA	NA	NA	A3088V	c.9263C>T	A3088V	3088	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32968840	G	A	Neutral	0.93	c.9271G>A_p.Val3091Ile	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	neutral	0.319	17.96	2.26905	0.33383	0.19147	0.904740642	0.85553	-2.02	5.9	4.16	0.47875	0.48581	0.00017	0.83479	0.5492	0.8217	-0.0047	0.70914	2.155	0.33832	0.74338	0.38722	0.4989	0.09184	0.16496	0.23934	0.096	0.26065	0.067	0.10326	-0.21	0.34399	0.075	0.63323	0.58356	0.547	-0.105425	-0.264022	rs80359194	NA	NA	NA	NA	NA	V3091I	c.9271G>A	V3091I	3091	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	This Study
13	32968844	A	C	Deleterious	1	c.9275A>C_p.Tyr3092Ser	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Familial_cancer_of_breast	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.869	25.6	5.252996	0.70989	0.3132	0.969844412	0.87526	-2.28	5.9	5.9	0.94921	0.84324	0	0.93176	0.7984	0.9398	0.7649	0.82459	2.595	0.4747	0.999534	0.42027	0.59096	0.95998	0.92612	0.89865	1	0.97092	1	0.56099	-2.61	0.91219	0	0.70096	0.8303	0.843	0.34929	0.316777	rs80359195	NA	NA	NA	NA	NA	Y3092S	c.9275A>C	Y3092S	3092	Class C65	Intermediate	0	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32968844	A	G	Deleterious	1	c.9275A>G_p.Tyr3092Cys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	deleterious	0.897	25.3	5.075665	0.68379	0.70216	0.995406115	0.87685	-2.3	5.9	5.9	0.94921	0.84324	0	0.93176	0.7984	0.9398	0.7649	0.82459	2.595	0.48359	0.999692	0.42027	0.59096	0.95998	0.92612	0.89865	1	0.97092	1	0.56099	-2.61	0.91219	0	0.70096	0.90807	0.917	0.326902	0.56115	rs80359195	7	NA	1	6.59E-05	62168	Y3092C	c.9275A>G	Y3092C	3092	Class C65	Neutral	0	0	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32968854	C	G	Deleterious	1	c.9285C>G_p.Asp3095Glu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Familial_cancer_of_breast	Pathogenic|Uncertain_significance		1	no_assertion_criteria_provided	deleterious	0.806	24.8	4.810095	0.64554	0.53893	0.991672892	0.90859	-2.76	5.9	3.53	0.39267	0.84324	0	0.93989	0.8212	0.92717	0.6635	0.83541	2.65	0.4051	0.986941	0.46662	0.45199	0.03506	0.08317	0.89865	1	0.97092	1	0.29716	-1.16	0.91219	0	0.29552	0.88497	0.896	0.497176	0.50909	rs80359198	NA	NA	NA	NA	NA	D3095E	c.9285C>G	D3095E	3095	Class C35	Deleterious	1	1	1	train	BRCA12_Funct	13	0.66	Guidugli et. al, 2013
13	32968861	T	C	Neutral	0.019	c.9292T>C_p.Tyr3098His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|ITMI|Sharing_Clinical_Reports_Project_(SCRP)|Counsyl|Invitae|GeneDx	BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|not_specified|Familial_cancer_of_breast|AllHighlyPenetrant|Neoplastic_Syndromes|_Hereditary|Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome	Benign|Likely_benign|Uncertain_significance			reviewed_by_expert_panel	neutral	0	0.006	-1.239776	0.02381	0.00238	0.128821731	0.80912	-1.45	5.89	1.6	0.2248	0.23044	0.0506	0.47902	0.1508	0.40332	-0.9538	0.01174	-0.975	0.08979	0.999992	0.40786	0.3151	0.16141	0.0598	0.02634	0	0.06334	0.002	0.03529	0.39	0.03329	0.775	0.4033	0.76257	0.77	-0.135902	-0.0739443	rs41293521	31	NA	15	2.55E-04	63796	Y3098H	c.9292T>C	Y3098H	3098	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2013
13	32968889	T	C	Neutral	0.941	c.9320T>C_p.Ile3107Thr	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	neutral	0.4	5.772	0.30812	0.12366	0.18247	0.894683694	0.80912	-1.45	5.89	0.408	0.15463	0.26426	0.023441	0.57081	0.2105	0.45904	-0.9176	0.16105	0.355	0.22454	0.997852	0.30833	0.46024	0.09551	0.20862	0.2128	0.055	0.26631	0.073	0.27869	-1.07	0.04719	0.658	0.33738	0.71109	0.709	-0.216035	-0.102461	rs397507425	1	NA	NA	8.24E-06	65576	I3107T	c.9320T>C	I3107T	3107	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32968936	A	G	Deleterious	0.999	c.9367A>G_p.Ser3123Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|GeneDx|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_multiple_submitters|_no_conflicts	deleterious	0.764	28.1	6.069202	0.83576	0.93134	0.998523462	0.86295	-2.12	5.89	5.89	0.94726	0.84324	0	0.93159	0.7979	0.94246	0.7864	0.82459	2.595	0.39366	0.977469	0.88722	0.63571	0.95998	0.92612	0.89865	1	0.87503	0.998	0.29716	-1.16	0.91219	0	0.69969	0.70784	0.705	0.203097	0.123203	rs80359208	1	NA	1	8.24E-06	66654	S3123G	c.9367A>G	S3123G	3123	Class C55	Neutral	0	0	1	test	BRCA12_Funct	13	0.66	Guidugli et. al, 2016
13	32968940	A	T	Deleterious	1	c.9371A>T_p.Asn3124Ile	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Emory_Genetics_Laboratory|Sharing_Clinical_Reports_Project_(SCRP)|Invitae	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Neoplastic_Syndromes|_Hereditary	Pathogenic|Uncertain_significance		1	criteria_provided|_conflicting_interpretations	deleterious	0.892	33	6.999966	0.9371	0.53581	0.991563388	0.9016	-2.64	5.89	5.89	0.94726	0.84324	0	0.95076	0.8522	0.95581	0.8932	0.83541	2.65	0.52429	0.99995	0.88722	0.72479	0.95998	0.92612	0.89865	1	0.97092	1	0.56099	-2.61	0.91219	0	0.69969	0.76964	0.778	0.308268	0.264128	rs28897759	2	NA	2	1.65E-05	66670	N3124I	c.9371A>T	N3124I	3124	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2013
13	32968941	C	A	Deleterious	1	c.9372C>A_p.Asn3124Lys	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.857	31	6.538953	0.90033	0.88904	0.998057365	0.89966	-2.61	5.89	3.14	0.34937	0.84324	0	0.92916	0.791	0.91304	0.555	0.83541	2.65	0.44964	0.998465	0.88722	0.67089	0.48811	0.44667	0.89865	1	0.97092	1	0.41209	-1.74	0.91219	0	0.30646	0.6042	0.573	0.0586445	-0.0561324	NA	NA	NA	NA	NA	NA	N3124K	c.9372C>A	N3124K	3124	Class C65	Deleterious	1	1	1	train	BRCA12_Funct	13	0.81	This Study
13	32968943	T	A	Deleterious	1	c.9374T>A_p.Leu3125His	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Invitae	Familial_cancer_of_breast|Breast-ovarian_cancer|_familial_2	Uncertain_significance			no_assertion_criteria_provided	deleterious	0.859	29.6	6.399052	0.8834	0.37459	0.980637975	0.90096	-2.63	5.89	5.89	0.94726	0.84324	0	0.95076	0.8522	0.95581	0.8932	0.83541	2.65	0.5297	0.999966	0.69624	0.5315	0.80647	0.76621	0.89865	1	0.97092	1	0.46638	-2.03	0.91219	0	0.69969	0.7831	0.793	0.321793	0.27142	rs80359209	NA	NA	NA	NA	NA	L3125H	c.9374T>A	L3125H	3125	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	This Study
13	32968943	T	G	Deleterious	1	c.9374T>G_p.Leu3125Arg	ENST00000380152	BRCA2	MODERATE	missense_variant							deleterious	0.85	29.9	6.458088	0.89089	0.91731	0.998368486	0.90096	-2.63	5.89	5.89	0.94726	0.84324	0	0.95076	0.8522	0.95581	0.8932	0.83541	2.65	0.54846	0.999981	0.69624	0.5315	0.80647	0.76621	0.89865	1	0.97092	1	0.41209	-1.74	0.91219	0	0.69969	0.89367	0.904	0.544674	0.560116	NA	NA	NA	NA	NA	NA	L3125R	c.9374T>G	L3125R	3125	Class C65	Deleterious	1	1	1	test	BRCA12_Funct	13	0.81	Guidugli et. al, 2016
13	32968952	G	A	Neutral	0.521	c.9383G>A_p.Arg3128Gln	ENST00000380152	BRCA2	MODERATE	missense_variant	Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	neutral	0.189	22.4	3.038596	0.42526	0.70405	0.995431581	0.84059	-1.82	5.89	0.403	0.15438	0.29474	0.011558	0.66805	0.2964	0.55652	-0.7918	0.424	1.32	0.24494	0.987407	0.56092	0.23736	0.23753	0.05504	0.3605	0.542	0.21233	0.034	0.22296	-0.81	0.12734	0.339	0.12931	0.68227	0.673	-0.22401	-0.15143	rs397507427	1	NA	NA	8.24E-06	66696	R3128Q	c.9383G>A	R3128Q	3128	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	This Study
13	32969018	C	T	Deleterious	1	c.9449C>T_p.Pro3150Leu	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Neoplastic_Syndromes|_Hereditary	Uncertain_significance			criteria_provided|_single_submitter	deleterious	0.884	33	6.922386	0.93286	0.96869	0.998959708	0.88782	-2.44	5.89	5.89	0.94726	0.84324	0	0.9375	0.8145	0.93792	0.7497	0.73215	2.22	0.81033	1	0.40786	0.50432	0.48811	0.44667	0.89865	1	0.97092	1	0.6078	-2.9	0.91219	0	0.90516	0.7234	0.724	0.240983	0.165228	rs80359217	NA	NA	NA	NA	NA	P3150L	c.9449C>T	P3150L	3150	Class C65	Intermediate	0	1	1	train	BRCA12_Funct	13	0.81	This Study
13	32969023	G	A	Deleterious	0.999	c.9454G>A_p.Glu3152Lys	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Sharing_Clinical_Reports_Project_(SCRP)|Invitae|GeneDx	Breast-ovarian_cancer|_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|BRCA1_and_BRCA2_Hereditary_Breast_and_Ovarian_Cancer|Neoplastic_Syndromes|_Hereditary	Likely_benign|Uncertain_significance			criteria_provided|_conflicting_interpretations	neutral	0.445	28.7	6.216902	0.85812	0.71098	0.995537224	0.8317	-1.71	5.89	4.1	0.46932	0.62918	4.00E-06	0.86227	0.6108	0.88054	0.3314	0.7759	2.38	0.45005	0.998496	0.26728	0.32515	0.21332	0.13381	0.60931	0.989	0.51286	0.67	0.25981	-0.98	0.6818	0.003	0.73542	0.75557	0.762	-0.03718	0.0554654	rs80359218	8	NA	NA	6.59E-05	66698	E3152K	c.9454G>A	E3152K	3152	Class C0	Neutral	0	0	1	test	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
13	32971042	A	G	Neutral	0.892	c.9509A>G_p.Asp3170Gly	ENST00000380152	BRCA2	MODERATE	missense_variant	Breast_Cancer_Information_Core_(BIC)_(BRCA2)|Ambry_Genetics|Invitae	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer|_familial_2|Neoplastic_Syndromes|_Hereditary	Benign|Uncertain_significance			reviewed_by_expert_panel	neutral	0.291	11.72	1.195308	0.20955	0.26133	0.953454688	0.82819	-1.67	5.94	0.419	0.15525	0.2309	0.050094	0.6887	0.3191	0.55302	-0.7978	0.43851	1.375	0.08979	1	0.39754	0.28736	0.25699	0.24593	0.16084	0.016	0.22257	0.039	0.38514	-1.6	0.27388	0.124	0.01416	0.7741	0.783	0.0801026	-0.0328414	rs80359224	1	NA	1	8.24E-06	66698	D3170G	c.9509A>G	D3170G	3170	Class C0	Neutral	0	0	1	train	BRCA12_Funct	13	0.03	Guidugli et. al, 2016
